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ABSTRACT 
Free microvascular flaps are a routine part of modern head and neck reconstructive 
surgery. The circulation of the flap depends on one artery and 1 to 2 veins, and it is 
extremely vulnerable to vascular compromises, such as thrombosis, hypotension, or 
vasoconstriction. The operated patients are kept sedated in the intensive care unit 
until the postoperative morning. Traditionally, sedation is achieved with propofol, 
which may have unfavorable effects on peripheral circulation. During sedation, the 
hemodynamic parameters of the patients and the flaps are being pharmacologically 
controlled by, e.g., norepinephrine, dobutamine, or dopamine, whose effects on 
denervated flap circulation is unclear. 
Dexmedetomidine causes more sleep-like sedation, and its effect on patient 
hemodynamics are more favorable than propofol. Moreover, fewer inotropes and 
vasopressors are needed. During dexmedetomidine sedation, the patient is calm and 
arousable. In previous studies, dexmedetomidine has been shown to cause 
vasoconstriction in denervated tissue, such as microvascular flaps. 
The first three postoperative days are considered to be most critical for flap 
survival because vascular compromise may rapidly lead to flap ischemia and re-
operations. Therefore, intensive monitoring of the flap during this period is 
recommended. Many monitoring methods have been previously described, but 
clinical follow-up by an experienced surgeon has been considered to be the gold 
standard. 
In the present study, tissue oxygen monitoring using the Licox monitoring system 
and microdialysis have been used for free flap postoperative follow-up. According 
to the findings of the present study, both are reliable methods for the monitoring of 
free flap oxygenation and metabolites (lactate, pyruvate, glucose, and glycerol) and 
are feasible for postoperative flap follow-up. Glycerol measured by microdialysis is 
a sign of cell destruction in the flap. 
According to the findings of present study, vasopressors and inotropes 
(norepinephrine and dopamine) have no negative effects on flap metabolites and 
circulation. Moreover, dexmedetomidine was found to be as good as propofol 
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regarding flap circulation and metabolites. These results mean that the postoperative 
sedation protocol can be changed in a better and safer way. 
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TIIVISTELMÄ 
Mikrovaskulaariset siirteet ovat nykyaikaisen hoitokäytännön mukaan merkittävä osa 
pään ja kaulan alueen syöpien hoitoa. Niiden avulla rekonstruoidaan poistettu 
kudosalue. Kielekkeiden pahin ongelmana on hapensaannin haavoittuvuus, koska 
kielekkeen verenkierron hoitaa vain yksi valtimo- ja 1-2 laskimosuonta, näin ollen se 
on hyvin herkkä pienillekin virtaushäiriöille. Syöpäleikatut potilaat pidetään 
sedatoituina anestesiateho-osastolla leikkauksen päättymisen jälkeen seuraavaan 
aamuun. Sedaatiossa käytetään rutiininomaisesti propofolia, joka laskee potilaan 
verenpainetta ja sen vaikutus perifeeriseen verenkiertoon saattaa olla epäedullinen. 
Sedaation aikana potilaiden verenpainetta ja samalla kielekkeiden verenvirtausta 
säädellään lääkkeillä (esim. Noradrenaliini, dobutamiini ja dopamiini), joiden 
vaikutus hermottamattoman mikrovaskulaarikielekkeen verenkiertoon on epäselvä.  
Propofolia optimaalisempi lääke postoperatiivisen sedaation saavuttamiseksi olisi 
dexmedetomidiini, jonka aiheuttama sedaatio on enemmän normaalin unen 
kaltainen. Sen aikana potilas on rauhallinen, mutta heräteltävissä. Näin ollen se 
vaikuttaisi optimaaliselta postoperatiiviseen sedaatioon. Lääke on myös 
vasoaktiivisesti edullisempi, eikä aiheuta niin voimakasta tarvetta verenkiertoa 
tukeville lääkkeille. Teoriassa dexmedetomidiinin käyttö voisi aiheuttaa ongelmia 
hermottamattomissa kielekkeissä, kuten mikrovaskulaarisiirteissä.  
Kielekkeiden kuntoa on seurattava hyvin tarkkaan leikkauksen jälkeiset 3 
vuorokautta, koska verenkierron heikkeneminen johtaa hyvin nopeasti kielekkeen 
tuhoutumiseen ja uusintaleikkauksiin. Seurantaa on perinteisesti suoritettu kliinisesti 
ja se vaatii kokeneen lääkärin arviointeja. Kielekkeiden kuntoa seuraamaan on 
kirjallisuudessa esitetty monia metodeja, tässä tutkimuksessa on käytössä Licox-
kudoshappimonitori ja mikrodialyysimonitorointi. Tutkimushavaintojen perusteella 
ne ovat luotettavia keinoja arvioida kielekkeen solutason hapettumista ja 
aineenvaihduntatuotteita (laktaatti, pyruvaatti, glukoosi, glyseroli) ja näin ollen 
käyttökelpoisia kudossiirteiden seurantaan. Glyseroli on siirteessä solutasolta 
mitattuna merkki kudostuhosta. 
Tutkimuksen perusteella voidaan sanoa, että kielekkeiden aineenvaihduntaan ja 
verenkiertoon ei saada negatiivisia vaikutuksia vasopressoreilla ja inotroopeilla 
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(noradrenaliini ja dopamiini). Myös dexmedetomidiini on yhtä hyvä siirteiden 
verenkierrolle ja aineenvaiduntatuotteille kuin propofoli.   Tutkimuksen perusteella 
voidaan muuttaa nykyistä postoperatiivisen sedaation hoitokäytäntöä parempaan ja 
turvallisempaan suuntaan.  
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1 INTRODUCTION 
In Finland, about 2.5% of all new malignant diagnoses are head and neck cancers, 
with over 800 new cases reported in 2016 (Suomen syöpärekisteri, 2018). Most of 
these malignancies are oral, pharyngeal, or laryngeal cancers. The treatment options 
vary from surgery to chemoradiation or a combination of the two. Patients with 
more advanced stage cancer often require major surgery that frequently leads to 
major tissue defects. The complex anatomy and functions of the head and neck 
region, such as speech and swallowing preservation, lead to the need for 
reconstructive surgery. Earlier, when these reconstructive procedures were not in 
everyday use, the patients were considered inoperable or similar surgeries were 
performed that involved closing wounds with straight sutures. As a result, patients 
could be left disabled for the rest of their lives, with a significantly lowered quality 
of life. This problem led surgeons to develop better reconstructive surgical 
techniques. Among these, pedicled local flaps, such as the deltopectoral, pectoralis 
major, and latissimus dorsi together with maxillofacial prostheses, were some of the 
first approaches aimed at improving patient outcomes. These approaches were, 
however, often bulky and led to significant deformities in the head and neck region.  
Free microvascular flaps, which are composed of combinations of vascularized 
areas of skin, muscle, or bone, were the next step in the development of 
reconstructive procedures. The flaps are harvested from the patient’s donor site and 
then transferred to the same patient as a spare part to reconstruct the tissue defect. 
The flap artery and vein and sometimes nerve are sutured micro-surgically end-to-
end with defect area vessels to produce flap circulation. The development of free 
flap reconstruction began in the 1950’s but became the gold standard for treatment 
in the head and neck region in the 1990’s (Steel & Cope, 2015). At Tampere 
University Hospital, free microvascular flaps have been used since the 1990’s.  
During surgery, the flap is harvested after or simultaneously with tumor removal. 
Then, the recipient vessels are prepared, the surgical defect is closed with the flap, 
and the graft vessels are sutured to the recipient vessels using the microvascular 
technique. This requires an expert team of microsurgeons that includes head and 
neck, plastic and maxillofacial surgeons. In the reconstruction of ablative defects in 
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the head and neck area, a wide variety of free flaps have been used. (Disa, Hu, & 
Hidalgo, 1997; Hidalgo, Disa, Cordeiro, & Hu, 1998) At Tampere University hospital 
and in this study, the majority of head and neck cancer reconstructions are 
performed using a radial forearm flap (RFA)(Soutar, Scheker, Tanner, & McGregor, 
1983) or a fibula flap (Hidalgo, 1989). These grafts are quite simple to harvest and 
they adapt well to covering surgical defects.  
Flap circulation is extremely sensitive to vascular compromises, such as 
thrombosis or vasoconstriction, which can, if not noticed early enough, lead to 
ischemia and even flap loss. This occurs because flap tissue cannot tolerate ischemia 
for more than 4 to 12 hours without necrosis and can, in the worst case, result in 
flap loss. (May, Chait, O'Brien, & Hurley, 1978) In such cases, immediate re-
operation to save the flap is required. As a result, surgeons have searched for more 
reliable monitoring methods to be able to detect ischemia early enough, and this has 
also influenced postoperative care in many ways.  
During the postoperative period, the fear of ischemia and flap loss is of significant 
importance. In many hospitals, the postoperative period starts with sedation and 
follow-up in the Intensive care unit (ICU). (Arshad et al., 2014; Marsh, Elliott, 
Anand, & Brennan, 2009) During this time, sedative medication, such as propofol, 
midazolam, or lorazepam, is administered to keep the patient stable and to prevent 
flap complications. To be able to ensure good perfusion to the flap and vital organs, 
the anesthesiologist faces a clinical dilemma as to whether to use vasopressors or 
fluids. (Sigurdsson & Thomson, 1995) Moreover, surgeons are concerned about 
using vasopressors so as to avoid the possible vasoconstriction of a flap artery. 
However, the recent literature seems to question this approach. (Hand et al., 2015; 
Harris, Goldstein, Hofer, & Gilbert, 2012) 
Traditionally, propofol has been used for postoperative sedation even though it 
is known to lower blood pressure and can cause difficulties in ensuring good 
perfusion pressure for the graft. Dexmedetomidine (DEX) is a rather new 
postoperative sedative used in the ICU, which could be more favorable in ensuring 
the perfusion pressure of the flap. On the other hand, DEX has been shown in one 
study to cause vasoconstriction in denervated tissues such as free flaps. (Talke, Lobo, 
& Brown, 2003)  
The purpose of the present study is to more carefully investigate tissue oxygen 
monitoring and microdialysis in free microvascular flap monitoring. Furthermore, 
comparisons between the effects of vasoactive and sedative medications were 
performed to evaluate the postoperative recovery of patients in the ICU. 
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2 REVIEW OF THE LITERATURE 
2.1 Microvascular free flaps 
Microvascular free flaps were introduced to head and neck reconstructions more 
than 50 years ago (Daniel & Williams, 1973; Hidalgo, 1989; Soutar et al., 1983; Steel 
& Cope, 2015) and they have been in routine use for 20 to 30 years (Spiegel & Polat, 
2007). Due to the complex anatomy and functions of the head and neck region, 
reconstructions are extremely important. Without them, radical surgery would lead 
to major postoperative problems lowering quality of life and resulting in long-lasting 
rehabilitation processes. During the last 30 years, more than 20 donor sites for free 
flaps in the head and neck region have been introduced, although an individual 
surgeon normally uses only a few of them. (Hidalgo et al., 1998; Steel & Cope, 2015)  
The most commonly used free flaps in head and neck surgery are septo- or 
fasciocutaneous containing skin, underlying subcutaneous tissue and fascia like the 
RFA, and anterolateral thigh (ALT). Sometimes these fasciocutaneous flaps may 
have external part of muscle or even bone based on vascular perforators. The flaps 
may also be muscular like latissimus dorsi, and rectus abdominis. Osteocutaneous 
composite flaps may also have perforator parts of muscle like fibula, scapula and 
crista iliaca. (de Bree et al., 2008; Hurvitz, Kobayashi, & Evans, 2006).  
2.1.1 Radial forearm flap 
The RFA is a septocutaneous flap based on the radial artery and cephalic vein and 
their perforators. It has been used for head and neck reconstruction since the 1980’s 
with excellent results. (Urken, Weinberg, Vickery, & Biller, 1990) The skin flap is 
raised together with superficial fat, the radial artery, its concomitant veins, and the 
superficial cephalic vein. The flap is usually thin and has a rich vasculature, making 
it reliable in reconstructive use, and it is therefore the flap of choice in the oral cavity 
(Moscoso & Urken, 1994). The anastomoses are easy to perform because its pedicle 
is relatively long and the vessels are reasonably large in diameter (Medard de Chardon 
et al., 2009). The limitations of the flap are its relatively small size and, in some cases, 
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donor site morbidity (Wong & Wei, 2010b). Lateral antebrachial cutaneous nerves 
can be raised together with the RFA and sutured in the side of the lingual nerve. This 
technique allowed 10 out of 17 patients to have sensory function in their tongue 
after reconstructive surgery. (Kuriakose, Loree, Spies, Meyers, & Hicks, 2001) 
2.1.2 Fibula flap 
Fibula flap is an osteoseptocutaneuous graft based on peroneal artery and its 
concomitant vein. It is extremely suitable for mandibular reconstruction but can also 
be used for maxillary reconstruction. The pedicle is sufficiently long to reach the 
neck vessels and a muscular part is also available if a bulkier flap is needed. Fibula 
graft has an intact bony cortex which makes it good for multiple osteotomies and 
dental implantation. (Y. M. Chang et al., 1998; Wong & Wei, 2010b) Sometimes the 
height difference of original mandible and fibular graft is too big for sufficient dental 
rehabilitation, in these cases a double-barrel fibular graft can be used (Horiuchi et 
al., 1995). Recently a computer-aided 3-dimensional operation planning has been 
used to shorten the ischemia time smoothening the reconstruction procedure 
(Kaariainen et al., 2016). Arteriosclerosis in the vessels of the leg is a contra-
indication for fibular flap, therefore the vessels of the leg need to be examined before 
operation (Young, Trabulsy, & Anthony, 1994). 
2.1.3 Anterolateral thigh flap 
The ALT is either a cutaneous, fasciocutaneous, or myocutaneous flap based on the 
lateral circumflex femoral artery, its two veins, and musculocutaneous perforator 
vessels. Large skin islands with subcutaneous tissue and the vastus lateralis muscle 
provide enough tissue to reconstruct remarkable tissue defects. Furthermore, its 
pedicle is long enough for anastomosis to the neck vessels. The ALT flap may also 
have multiple skin islands but still has only minor donor site morbidity. In head and 
neck reconstruction, this flap may sometimes be even too bulky. (Wong & Wei, 
2010a) The only true contraindication of this flap is the absence of skin perforators, 
which is extremely rare (Wong, Wei, Fu, Chen, & Lin, 2009). 
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2.1.4 Rectus abdominis flap 
The rectus abdominis is a musculocutaneous flap based on the deep inferior 
epigastric artery and vein. It has been widely used in breast reconstruction and has a 
large skin island possibility together with the rectus abdominis muscle. Its donor site 
morbidity is minimal, and it is reasonably easy to harvest. The flap has been used in 
orbital and skull base reconstruction and also in the neck, face, mouth, and pharynx. 
The pedicle length of the flap is about 7 cm. The length can, however, vary, 
depending on the entrance of the vessels into the muscle, although the pedicle can 
be lengthened by cutting the muscle fibers around it but still it may cause some 
problems in the head and neck area. (Kroll & Baldwin, 1994; Urken, Turk, Weinberg, 
Vickery, & Biller, 1991) 
2.2 Complications in free flap surgery 
According to Sigurdsson and Thompson, free flaps differ from normal tissue in 
several aspects, such as having already suffered from ischemia during transfer, being 
denervated, and being without lymphatic drainage leading to a risk of edema. Also, 
during the first 6 to 12 postoperative hours, the blood flow to the flaps decreases to 
half of the pre-transfer values before slowly returning to normal, yet the arteries still 
respond to physical and pharmacological stimuli. (Daniel & Kerrigan, 1979; 
Sigurdsson & Thomson, 1995) Different types of flaps have been shown to have 
significant differences in their blood flow. Mucke et al. studied the perfusion of four 
different types of free flaps with laser doppler flowmetry and found that after the 
first postoperative day the perfusion of septocutaneous flaps, such as the RFA, was 
much better when compared with muscular like fibula or ALT flaps. (Mucke et al., 
2014) 
Because only one artery and normally only one or two veins are responsible for 
the circulation of the flap, vascular complications may jeopardize the survival of the 
whole flap. Suh et al. studied 400 consecutive head and neck free flaps and reported 
that perioperative complications occurred in 36% of the cases. Reconstructive 
complications such as infection, salivary fistula, partial or total flap necrosis, donor 
site problems occurred in 19% and the rest were medical complications, such as 
pulmonary, cardiac, and infective problems. Of these reconstructive complications, 
only 0.8% led to total flap necrosis and flap loss. Partial flap necrosis occurred in 
3%. (Suh et al., 2004) In a study by Winterton et.al., the vascular reasons leading to 
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re-operation were 18.7% arterial and 27.1% venous occlusions. Hematoma occurred 
in 43.5% of the cases reported. (Winterton et al., 2010)  
Although the survival rate of the free flap is generally between 95% and 98% 
(Disa et al., 1997; Hidalgo et al., 1998; Spiegel & Polat, 2007), every failure is still 
devastating for the individual and results in the need for re-operations and a 
lengthened hospital stay.  The failure of free flaps may occur on multiple levels, such 
as harvest, complex inset of the flap, non-ideal pedicle geometry, prolonged ischemia 
time, and inadequate postoperative care. (Luu & Farwell, 2009) In addition, previous 
irradiation and previously failed microvascular operation have been reported to 
predispose to flap failure. (Arshad et al., 2014; Mucke et al., 2016) Free flaps can 
tolerate ischemia from 4 to 8 and up to 12 hours. Therefore, it is during this time 
period that revision should be performed to save the flap. (Carroll & Esclamado, 
2000; Esclamado & Carroll, 1999; May et al., 1978)  
More than 80% of vascular occlusions take place in 1 to 4 postoperative days. Bui 
et al. studied 1193 free flaps, 883 of which were in the head and neck. Of these, 71 
patients were re-operated, and the mean time from primary operation to re-
exploration was 2.5 days. In breast reconstructions, the majority were re-operated 
on the first postoperative day. However, in head and neck reconstructions only 32% 
were re-operated on the first postoperative day, and one was operated as late as day 
7. Their main finding was that salvaged flaps were re-operated sooner after detection 
than failed flaps (4 vs 9 hours). (Bui et al., 2007) Similar findings were also reported 
in a study by Brown et al. who found that vascular occlusions later than two days 
from the primary operation led to flap loss more often than in days 1 and 2 (Brown 
et al., 2003). Kadota et. al. reported that 54% of the thrombosis after day 5 was 
caused by wound infection (Kadota, Sakuraba, Kimata, Yano, & Hayashi, 2009). 
Winterton et al. studied 2567 free flaps and also stated that re-operation should take 
place immediately if any doubt of imminent flap failure occurs (Winterton et al., 
2010). 
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2.3 Monitoring of microvascular flap  
 
To notice vascular compromises early enough is the most important reason for free 
flap monitoring. To achieve this goal, most surgeons use clinical monitoring 
techniques, such as observation of flap color and turgor as well as pinprick testing 
(Hirigoyen, Urken, & Weinberg, 1995; Jallali, Ridha, & Butler, 2005; Spiegel & Polat, 
2007).  These methods should be repeated every 1 to 4 hours and require repeated 
control visits for the first postoperative days.  
In a rabbit model, Prasetyono and Adianto studied cutaneous flap color changes 
after clamping the flap artery or vein. Surprisingly, they noticed that with a clamped 
artery the color change was not noticeable at all. When the vein was clamped, it took 
more than half an hour before any noticeable change in graft color occurred. 
(Prasetyono & Adianto, 2013) Muscular flaps, such as the latissimus dorsi, or 
muscular and bony flaps, such as the fibula, are more difficult to monitor because of 
the complex vascularity of muscle and bone. Postoperatively, the flap surface may 
have a spotted appearance making clinical observation difficult and, in the worst 
case, can result in delays if re-operation is needed. In a previous study, muscular flaps 
showed irreversible histopathological changes, such as red cell platelet thrombus, 
dilatation of postcapillary venules, endothelial swelling, and microhemorrhage 
formation, already within 6 hours of ischemia (Siemionow, Manikowski, & 
Gawronski, 1995).   
Complications can be detected if the flap follow-up is meticulous and the flap is 
visible. However, in head and neck microvascular surgery, some flaps are situated 
deep in the hypopharynx or oropharynx and are only partly visible, if at all. These 
flaps are called buried flaps, and their clinical follow-up, through direct visualization 
or by checking the vital signs of the flap, is extremely difficult or even impossible. 
Disa et al. analyzed a total of 750 free flaps with a loss rate of 1.8% for visible flaps 
and 6.5% for buried flaps, with a 0% salvage rate for buried flaps. (Disa, Cordeiro, 
& Hidalgo, 1999)  
Buried flaps remain a challenge in head and neck surgery because their clinical 
monitoring is impossible. Moreover, doppler ultrasound may be difficult to use with 
large carotid arteries nearby. Some monitoring methods, such as tissue temperature 
monitoring inside of the intraoral cavity, are good for external flaps but are not 
suitable for buried flaps. Some surgeons try to bypass this problem by creating an 
exteriorized flap or distal skin paddle to allow clinical monitoring and to provide 
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indirect information about the “real” flap. However, the external part may have 
vascular complications of its own or vice versa, so interpreting the information must 
be done carefully. (Dodakundi et al., 2012; Hallock, 1991; Hallock, 2017; Kashimura, 
Nakazawa, Shimoda, & Soejima, 2013; Laporta, Longo, Sorotos, Pagnoni, & 
Santanelli Di Pompeo, 2015; C. T. Lin, Chen, Chen, & Tzeng, 2014; Tan et al., 2012) 
Another reason for using different monitoring devices is to ease the workload of 
the surgeon. The number of surgeons capable of performing microsurgery among 
head and neck surgeons and otolaryngologists seems to have gradually increased in 
recent years, but still remains low in many centers. In 2007, Spiegel and Polat 
surveyed otolaryngologists in the United States and found that in an average medical 
facility performing head and neck surgery there was on average 1 to 2 surgeons able 
to perform microvascular surgery. In 2018, this number had increased to between 2 
and 3. (Kovatch, Hanks, Stevens, & Stucken, 2018; Spiegel & Polat, 2007) Therefore, 
routine control visits have to be also performed by specialized nurses or resident 
physicians. Patel et al. surveyed the records of 1085 patients from different hospitals 
with different resident flap control frequencies ranging from 1 hour to as much as 
even 12 hours. They found no difference in flap salvage rate between institutions, 
regardless of the resident flap monitoring frequency. Furthermore, they stated that 
the number of routine resident control visits could be decreased and the workload 
of the surgeons made easier, however the flaps were still controlled every hour by 
trained nurses. (Patel et al., 2017)  
Prior to 1995, most of the monitoring methods used were non-invasive. 
(Hirigoyen et al., 1995) Since then, an optimal postoperative follow-up method for 
free flaps has been sought.  There are many follow-up methods in everyday use, but 
still no gold standard follow-up method exists. An ideal monitoring method should 
be harmless to the patient, easy-to-use, reliable in rapidly detecting vascular 
compromise, and continuously cost-effective and simple and safe to use. The 
method should also be able to monitor muscular, bony, and cutaneous as well as 
buried and superficial flaps. (Furnas & Rosen, 1991) Because at present no such 
method exists and there is no evidence of a particular technique being superior to 
others, many different devices are in use. Indeed, the monitoring devices used seem 
to vary according to the personal preferences of surgeons and institutions. Even if 
the most obviously unsuitable monitoring methods are left out, there are still many 
feasible ones that can be used for the monitoring of free microvascular flaps. Some 
methods, such as tissue oxygen (PtiO2) monitoring and Near-infrared spectroscopy 
(NIRS), directly measure oxygen or oxygenized hemoglobin in the flap. Microdialysis 
(MD) measures the metabolites, and thus indirectly the status of circulation in the 
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flap. Doppler ultrasound detects the speed of the blood flowing in the flap arteries 
and veins, which also indirectly reflects the flap oxygenation. Ultrasound can be 
delivered through the skin of the neck to the pedicle artery, directly to the flap, or 
by an implantable device around the vein or artery of the flap. (Cervenka & Bewley, 
2015; Chae et al., 2015; Kaariainen, Halme, & Laranne, 2018)  
 
The reason for using a monitoring device is the time of response compared with 
clinical follow-up. Some of the monitoring methods are, however, quite expensive. 
For example, MD adds around 500€ each time it is used, and therefore the cost-
effectiveness of such methods should also be calculated. (Smit, Zeebregts, Acosta, 
& Werker, 2010) There have been numerous studies on the cost-effectiveness of 
monitoring methods. The results of these studies, however, seem to be controversial. 
Some authors state that routine monitoring even with rather expensive devices seems 
to be cost-effective. On the other hand, Subramaniam et al. calculated that to be 
cost-effective with only clinical monitoring the flap failure rate should be 15.8% or 
more, being less than 5% in most microsurgical units. (Pelletier, Tseng, Agarwal, 
Park, & Song, 2011; Poder & Fortier, 2013; L. Setala, Koskenvuori, Gudaviciene, 
Berg, & Mustonen, 2009; Subramaniam, Sharp, Jardim, & Batstone, 2016)  
In conclusion, most authors agree that the monitoring of the flaps is important 
to be able to find vascular compromises in time to save the flap. (Brown et al., 2003; 
Kruse, Luebbers, Gratz, & Obwegeser, 2010) In 2009, Abdel-Galil and Mitchell 
reviewed the monitoring literature. They reported that clinical bedside monitoring 
seems to be the only universally accepted method even though they could not find 
good prospective randomized studies to confirm this. (Abdel-Galil & Mitchell, 
2009a; Abdel-Galil & Mitchell, 2009b) The monitoring frequency and the methods 
are controversial because there also seems to be the pros and cons in every method. 
Without a universal gold standard, follow-up methods will continue to be selected 
based on the individual opinions of microvascular surgeons and the availability of 
different methods in each institution. Critical studies on free flap monitoring in the 
literature do not distinguish between flaps that are situated in places that are visible, 
such as the extremities, or hidden, for example, inside the oropharynx, pharynx and 
larynx. Therefore, in head and neck flap monitoring, a reliable monitoring device is 
desirable. 
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2.3.1 Monitoring methods 
2.3.2 Non-invasive monitoring methods 
Non-invasive monitoring methods cause no additional trauma to the flap or to the 
patient. Many non-invasive methods have also been described in head and neck free 
flap surgery. However, with the exception of clinical monitoring and Doppler 
ultrasound, questionnaires completed by head and neck surgeons show that only a 
few of them are in everyday use. (Hirigoyen et al., 1995; Jallali et al., 2005; Spiegel & 
Polat, 2007)  
Some non-invasive monitoring methods, such as surface temperature 
monitoring, seem to be more experimental and have only been used clinically by a 
few surgeons or were used purely for research. These methods include 
microlightguide spectrophotometry, green light photoplethysmography, and 
impedance plethysmography. (Concannon, Stewart, Welsh, & Puckett, 1991; Holzle, 
Loeffelbein, Nolte, & Wolff, 2006; Khouri & Shaw, 1992; Wolff, Marks, Uekermann, 
Specht, & Frank, 1996)  
2.3.2.1 Bedside clinical monitoring 
Bedside clinical monitoring is the only method that is universally accepted as the 
gold standard for free flap monitoring. Clinical monitoring means flap appearance, 
color and turgor observation, and pinprick testing. The bedside monitoring of 
clinical signs is time-consuming, but for most flaps sufficient, although results may 
depend on the experience and subjective opinions of the person in charge. Chubb 
et al. studied the clinical monitoring of 1140 free flaps by nurses or junior residents 
whose suspicions led them to consult a senior surgeon. The flaps were assessed at 
half-hourly intervals for the first postoperative day, 1 hourly intervals for the second 
day, and gradually extending the observation intervals until they were stopped by the 
fifth to seventh postoperative day. Their results were a good flap salvage rate and 
low false-positive rate. Moreover, they stated that every new monitoring method 
study should be compared with the results of their study. (D. Chubb et al., 2010) In 
clinical monitoring, digital images can be sent to the surgeon in charge via the 
Internet or cell phone to speed-up the re-exploration process (Hwang & Mun, 2012; 
Varkey et al., 2008). 
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2.3.2.2 Doppler Ultrasound 
Surface Doppler monitoring with low–frequency continuous-wave ultrasound can 
be used in combination with clinical monitoring. It is simple to use, and the 
equipment required is cheap. The device is handheld, and the sound of arterial or 
venous pulsation is the main signal. The device is used by 30% to 80% of head and 
neck microsurgeons. (Hirigoyen et al., 1995; Jallali et al., 2005; Spiegel & Polat, 2007) 
In the head and neck region, however, this system has certain limitations. For 
example, close proximity to the carotid artery and jugular veins can sometimes make 
it very difficult to detect whether the Doppler sound comes from the pedicle artery 
(Abdel-Galil & Mitchell, 2009a). Moreover, it is also difficult to use with buried flaps. 
In addition, arterial pulsation can also be heard after venous occlusion, thus 
lengthening the decision-time for re-operation (Smit et al., 2010).  
2.3.2.3 Laser Doppler flowmetry 
Laser Doppler flowmetry is a continuous non-invasive method for the measurement 
of tissue oxygen and perfusion. Laser Doppler measures red blood cell movement 
from the surface of the flap only to a depth of 8 mm, which makes it unsuitable for 
buried flaps. The advantage of the system is two numeral parameters: average 
velocity of blood cells and total intensity of the reflected light, which is inversely 
proportional to total blood contained in the tissue. (Abdel-Galil & Mitchell, 2009a; 
Smit et al., 2010) The trend of perfusion values is important but not the absolute 
value per se. Hence, according to Yuen and Feng who found this system reliable in 
232 patients, the learning curve of the method is longer. (Yuen & Feng, 2000) 
2.3.2.4 Colour duplex sonography 
Color duplex sonography is a non-invasive method to visualize the arterial and 
venous flow inside flap pedicle vessels. The flow can also be quantitated. However, 
experienced personnel are needed to interpret the findings. In a study by Rosenberg 
et al., a radiologist together with a microsurgeon examined the flaps, making it 
slightly impractical in everyday use (Rosenberg, Fornage, & Chevray, 2006). The 
value of color duplex sonography in searching for the perforators of free flaps has 
been previously shown, although in the era of CT- and MRI-angiography its role has 
become limited(Smit, Klein, & Werker, 2010)(Smit, Klein, & Werker, 2010)(Smit, 
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Klein, & Werker, 2010)(Smit, Klein, & Werker, 2010)(Smit, Klein, & Werker, 
2010)(Smit, Klein, & Werker, 2010)(Smit, Klein, & Werker, 2010)(Smit, Klein, & 
Werker, 2010)(Smit, Klein, & Werker, 2010) (Rand, Cramer, & Strandness, 1994; 
Smit et al., 2010) The method has also been used in the monitoring of free flaps after 
surgery mainly to confirm the status of the anastomoses after displacement of an 
implantable doppler-probe. (Few, Corral, Fine, & Dumanian, 2001; Khalid, 
Quraishi, Zang, Chadwick, & Stack, 2006; Rosenberg et al., 2006; Stone, Dubbins, 
& Morris, 2001)  
2.3.2.5 Near-infrared spectroscopy 
Near-infrared spectroscopy (NIRS) is a non-invasive and continuous method used 
for monitoring the end-organ delivery of oxygen. Near-infrared light (650-900 nm) 
is delivered into the tissue up to a depth of 20 mm. The absorption of the light varies 
according to the level of the oxygen in the hemoglobin, which can then be measured. 
The concentrations of hemoglobin and deoxygenated hemoglobin are calculated and 
the variation changes detected. (Y. Chen, Shen, Shao, Yu, & Wu, 2016; Steele, 2011) 
Kagaya & Miyamoto performed a meta-analysis of scientific articles dealing with 
aspects of NIRS and reported a success rate of 99.5% and a flap salvage rate of 
91.1%. Moreover, vascular compromises could be detected with sensitivity of 99.1% 
and specificity of 99.9% even earlier than by the other monitoring methods analyzed. 
(Kagaya & Miyamoto, 2018) In the method, a probe is placed on the skin and secured 
with a sticking plaster. The method can also be used inside the oral cavity because 
of a special silicon probe that can be sutured in place. Moisture under the probe or 
migration of the probe may cause some false alarms. The probe should also be 
covered to avoid any light disturbance. Furthermore, this system is not really suitable 
for buried flaps. (Kaariainen et al., 2018) 
2.3.3 Invasive monitoring methods 
Invasive monitoring methods mean minimally invasive techniques for free flap 
follow-up. Numerous methods have been described for experimental purposes and 
everyday clinical use. Among these are implantable Dopplers, tissue temperature 
monitoring, tissue PH monitoring, tissue oxygen monitoring, and microdialysis. 
(Abdel-Galil & Mitchell, 2009b) Even a Positron emission tomography (PET) scan 
has been used as a monitoring system in a clinical trial with good results (Schrey, 
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Kinnunen, Grenman, Minn, & Aitasalo, 2008). Some of these methods are not 
suitable for monitoring intraoral flaps. For example, a temperature probe measures 
the inside natural cavity temperature, which does not change remarkably in cases of 
vascular compromise. 
2.3.3.1 Implantable Doppler 
Implantable Doppler probes allow the continuous and direct monitoring of the flap 
vessels, and they can be attached to either pedicle veins or arteries. The cuff is made 
out of silicone and comprises a 20 MHz ultrasonic probe and an easily removable 
wire. In some cases, the probe wire may be accidentally detached leading to a false 
positive result. (K. P. Chang, Lin, & Lai, 2007; Um et al., 2014) The probe 
continuously provides a voice signal either from the venous or arterial pulse or both. 
Any weakening or loss of the sound may suggest vascular compromise. The decision 
whether to wrap the probe around an artery or vein is based on personal experience. 
Chang et al. studied 439 patients and found that arteries were superior to veins with 
better sensitivity and specificity. However, in cases of venous thrombosis, the artery 
may have a pulsation sound that lasts for hours, leading to false negative findings. 
No additional information was found on probes wrapped around both veins and 
arteries. (E. I. Chang et al., 2016) Wax studied 1142 flaps with implantable Doppler 
and found only 8 false positives but also 10 false negative flap compromises, and the 
overall flap survival rate was 97%. He found the system to be reliable enough for 
flap monitoring. (Wax, 2014) In buried flaps, implantable Doppler has been 
associated with numerous false positive findings that have led to unnecessary 
explorations (Rosenberg et al., 2006). 
The ultrasound probe can also be attached to venous coupler sets, which is a 
device for making end-to-end venous anastomosis. This is called the flow coupler 
technique, which is easy to apply, simple to use, and monitoring is reliable. (D. P. 
Chubb, Rozen, Whitaker, & Ashton, 2011; Oliver, Whitaker, Giele, Critchley, & 
Cassell, 2005) The technique works as well as other implantable Doppler probes 
around veins. However, in a recent study, this system has been found to result in 
significantly more vascular thrombotic events than a coupler without the Doppler 
system. (Kempton, Poore, Chen, & Afifi, 2015)  
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2.3.3.2 Tissue oxygen monitoring 
Tissue oxygen (PtiO2) monitoring has been widely used by neurosurgeons to measure 
brain oxygen levels. It comprises a Licox® touch-screen monitor, which shows tissue 
oxygen tension and trends in numerical values, together with a flexible probe. This 
method was first described in free flaps by Hirigoyen in a rabbit model (Hirigoyen 
et al., 1997), and it has since been used in several institutions including Tampere 
University Hospital. Several studies of its usefulness have been published. (Jonas et 
al., 2013; Kamolz, Giovanoli, Haslik, Koller, & Frey, 2002; Raittinen, Laranne, Baer, 
& Pukander, 2005; Wechselberger et al., 1997) 
Oxygen dissolved in the interstitial fluid corresponds to the availability of oxygen 
at the cellular level in the flap.  However, hemoglobin levels, microcirculation, and 
systemic oxygen levels also influence the levels of flap oxygenation. When the 
monitoring probe is inserted in the tissue, its oxygen diffuses through the 
polyethylene wall of the probe to a negatively polarized precious metal in the inner 
electrolyte chamber, resulting in O2 molecules polarizing into OH-ions. The 
polarization can be detected as an electric current. The current from the O2-
reduction is the raw signal of the sensor. The reactions in the probe are reversible 
making the measurements stable and continuous.  
A major limitation of the PtiO2 monitoring system is the sensitivity of the probe 
to micro movements. The probe may be detached or it may lower PtiO2 readings, 
and therefore even lead to unnecessary re-operations. (Jonas et al., 2013; 
Wechselberger et al., 1997) 
Tissue oxygen levels are considered to efficiently reflect the level of tissue 
perfusion. If the flap perfusion is increased, the PtiO2 levels approach that of 
systemic arterial blood. On the other hand, circulatory impairment of the flap quickly 
results in descending oxygen pressure. (Abdel-Galil & Mitchell, 2009b) The PtiO2 -
levels are shown as mmHg and are in proportion to the measured temperature. The 
trend of PtiO2 -levels is important in the follow-up, but they are not the absolute 
value per se, which lengthens the learning curve of this method. (Kaariainen et al., 
2018) Normally, after anastomosis, the PtiO2 -levels rise rapidly to the peak level 
before starting gradually to slide. However, the readings are reliable for the first few 
minutes after flap circulation is opened. A steeper slide or a simple drop under 10 
mmHg predict vascular compromise, if it is not solved by controlling the probe and 
positioning the patient’s head or other conservative methods within 30 minutes 
(Hofer, Timmenga, Christiano, & Bos, 1993).  
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Lin et al. compared time before and after tissue oxygen monitoring in their study 
consisting of 614 free flap patients. Their percentage of re-operations was identical, 
but the rate of flap loss was significantly lower in the tissue oxygen monitoring group. 
These findings suggest that PtiO2 monitoring makes it possible to observe vascular 
compromises early enough to be able to save the flap with re-operation.(S. J. Lin et 
al., 2011) 
Recently, Arnez et al. stated that the results of PtiO2 monitoring were similar to 
those of clinical bedside monitoring. Their study consisted of 87 patients, of whom 
47 had head and neck tumors, and they reported 13% false positive results but no 
false negatives. For a flap monitoring device, this is a good feature and means that 
no flap compromises occur without an alarm. (Arnez et al., 2018) 
2.3.3.3 Microdialysis 
Microdialysis (MD) is a method that continuously measures the extracellular 
molecules of individual tissues and organs. Its main principle is the gradient 
difference in extracellular space and flowing microdialysate by mimicking the blood 
flow in the capillaries. (Lonnroth & Smith, 1990; Ungerstedt, 1991)  
Microdialysate (isotonic Ringer’s solution) is circulated by a special pump through 
a thin dialysis tube inserted in tissue using a special probe. The molecules travel along 
gradient differences through a semipermeable membrane into the dialysate, which is 
then collected into a microvial. The collected fluid sample reflects the composition 
of the extracellular fluid in the investigated tissue. The samples can be collected 
continuously for hours or days and then analyzed chemically using a specific 
microdialysis device or other analyzers, such as radioimmunoassay and mass 
spectrometry. The gradient differences between the dialysis tube and the extracellular 
fluid are levelled both ways. This allows medication, for example, to be administered 
locally into the tissue via microdialysate. There are different commercial kits available 
for analyzing microdialysate. A commercial analysis kit has reagents that can measure 
oxygen dependent metabolite levels, such as glucose, lactate, and pyruvate, in the 
extracellular fluid, and thereby reflects the circulatory status of the investigated 
tissue. Pyruvate is produced from glucose by glycolysis, and therefore both of them 
reflect the amount of fresh blood circulating in the tissue. Lactate is produced as an 
end product in pyruvate breakdown. Small amounts are normal in extracellular fluid, 
but when levels are elevated considerably, it reflects anaerobic metabolism and 
suggests insufficient blood flow. 
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Microdialysis was first introduced to monitor free flap metabolism by Röjdmark 
et al. in 2002. Since then, it has been used in free flap follow-up both experimentally 
and nowadays also in everyday clinical use (Edsander-Nord, Rojdmark, & Wickman, 
2002; Jyranki, Suominen, Vuola, & Back, 2006; Röjdmark, Heden, & Ungerstedt, 
1998; Rojdmark, Blomqvist, Malm, Adams-Ray, & Ungerstedt, 1998; L. P. Setala et 
al., 2004; Udesen, Lontoft, & Kristensen, 2000). MD is able to measure true 
metabolic changes inside the flap tissue while other monitoring systems more or less 
reflect or measure blood flow inside the flap vessels or the flap itself (Su, Im, & 
Hoopes, 1982). Therefore, MD has been found to be extremely sensitive in noticing 
even small changes in the microenvironment of the flap. For example, the effect of 
hematoma around the probe has been seen to have an effect on MD metabolites: 
both lactate and glucose remain low, which itself is a confusing issue (Kristensen, 
Ladefoged, Sloth, Aagaard, & Birke-Sorensen, 2013). One major advantage in both 
MD and PtiO2 measuring devices is that they can be attached to muscle or fat and 
do not need a skin part to work in a free flap (Jyranki et al., 2006). 
 Frost et al. compared MD with implantable Doppler and clinical bedside 
monitoring in a 20-patient series. They found MD to be feasible but noticed many 
technical problems with the pump or analyzer and error measurements. They stated 
that all of the monitoring methods discovered flap compromises early enough for 
successful salvage surgery. However, MD and Doppler detected flap compromises 
sooner than clinical monitoring, MD with 100% specificity. (Frost et al., 2015) 
Role of glycerol in flap monitoring 
Extracellular glycerol is thought to mirror the level of cellular injury, and levels can 
be detected by MD. Ischemia, and hence impaired energy production, is thought to 
result in calcium entering the cells. This activates phospholipids, which in turn 
hydrolyze cell membranes and release glycerol. (Allen, Chen, Seaber, & Urbaniak, 
1995) According to Udesen et al., the normal course of surgery elevates MD glycerol 
levels only moderately before they normalize. However, in a failed free flap, glycerol 
levels rise rapidly, reflecting massive cellular destruction (Udesen et al., 2000). 
Confusingly, the reason for elevated glycerol levels post-operatively is thought to be 
adipose tissue lipolysis modulated by endogenous catecholamine, which is the result 
of sympathetic stress caused by the operation (Fellander, Eleborg, Bolinder, 
Nordenstrom, & Arner, 1996). However, Udesen et al. questioned this because they 
found glycerol levels were only elevated in the flap not in the control tissue. This 
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leads to some confusion as to whether the slight elevation is caused by sympathetic 
tonus per se or only by cellular damage (Udesen et al., 2000).  
 
Role of lactate/pyruvate ratio in flap monitoring 
Tissue ischemia due to arterial or venous occlusion changes tissue metabolism from 
an aerobic to an anaerobic direction. This change is reflected by a decline of glucose 
and pyruvate and an elevation of lactate, and the lactate/pyruvate-ratio (L/P ratio) 
can be measured by MD.(L. Setala et al., 2006) Glucose and L/P ratio are the most 
sensitive to ischemia (Contaldo et al., 2005). Jyränki et.al studied microdialysis in 
intraoral free flaps. They found that in successful flaps the L/P ratio did not exceed 
25, but in the case of vascular compromise it was elevated remarkably. After re-
operation, however, the levels quickly returned to normal. Therefore, the L/P ratio 
is a reliable indicator for detecting ischemia. (Jyranki et al., 2006) Setälä et al. found 
the L/P ratio median to be 12, and 98% of all readings were under 32. (L. Setala et 
al., 2006)   
2.3.3.4 Multimodal monitoring 
Multimodal monitoring means using two or more monitoring methods or devices in 
the same flap. As the results of single monitoring methods are more or less 
controversial, the idea of multimodal free flap monitoring with different devices 
along with clinical follow-up in clinical practice seems almost absurd. However, this 
is normal practice for critically ill patients in neurosurgical care. For example, PtiO2 
monitoring and MD have been used together.(De Georgia, 2004) In theory, similar 
multimodal monitoring provides much more information about the flap tissue. For 
example, in cases where PtiO2 levels start to decrease slowly, even though the flap 
still looks good, MD could strengthen the decision to revise should the L/P ratio 
start to significantly increase. Similarly, color-duplex sonography has been used to 
confirm blood flow when an implantable Doppler probe was accidentally detached 
(Rosenberg et al., 2006). 
In everyday practice, multimodal free flap monitoring is too complicated and too 
expensive. Yet, in clinical studies, it has been widely used to confirm suggested 
results or to control the feasibility of a new monitoring method. Schrey et al. used 
PtiO2 monitoring together with a PET scan and found that in estimating the need for 
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revision surgery, a PET scan provides vital extra information cost-effectively. For 
example, PET could confirm low PtiO2 -levels as being real ischemia. (Frost et al., 
2015; Nunes et al., 2007; Rosenberg et al., 2006; Schrey et al., 2008)  
2.4 Maintaining perfusion pressure during postoperative period 
2.4.1 Background 
Head and neck microvascular surgery and the postoperative period are challenging 
for anesthesiologists. Operations last a long time, remarkable blood loss may occur, 
and patients often have comorbidities combined with heavy smoking and alcohol 
abuse (Blot et al., 1988). In many institutions, patients are sedated until the next 
morning to ensure flap survival. Prolonged sedation may, however, cause 
vasodilation and reduced mean arterial pressure (MAP), which in turn could be 
hazardous for the flap. To prevent this, actions to normalize the hemodynamic 
stability, such as elevating MAP by filling up the blood vessels or by increasing their 
tonus, should be taken. Traditionally, this has meant excessive IV liquid use, often 
leading to flap or even pulmonary edema. (Angelini, Ketzler, & Coursin, 2001; Hagau 
& Longrois, 2009; Sigurdsson & Thomson, 1995) To avoid these untoward side 
effects, the use of vasopressors, such as dopamine, dobutamine. or norepinephrine 
(NE), is often necessary (Massey & Gupta, 2007). On the other hand, there is a risk 
of possible vasoconstriction with flap ischemia. Hence, the use of vasopressors is 
still controversial, as shown by Gooneratne et al. (Gooneratne, Lalabekyan, Clarke, 
& Burdett, 2013) In a recent study from USA, Kovatch et al. asked microsurgeons 
for their opinions of vasopressors. Of those questioned, only 6% accepted them and 
63% allowed them but preferred not to use them (Kovatch et al., 2018). Previously 
in Tampere University Hospital’s guide for anesthesiologists, colloid was favored, 
and if any medication was needed, only dobutamine was allowed (Ingberg P, 2006). 
2.4.2 Effects of autonomic nervous system 
The human autonomic nervous system is responsible for many reactions vital for 
survival. It is anatomically and functionally divided into sympathetic and 
parasympathetic systems, both of which are active all the time. The sympathetic 
system predominates during emergency reactions and exercise and the 
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parasympathetic system during quiet rest, when the body is supposed to conserve 
energy and regulate basic body functions. The one that is the more active depends 
on the balanced level of inhibition and activity in the end organs.  
Circulating catecholamines, such as NE and epinephrine, act through adrenergic 
receptors that can be divided to alpha and beta receptors, both of which are divided 
into subtypes. Alpha receptors are situated in the heart, liver, brain, and arterioles 
causing vasoconstriction and glycogenolysis. Beta receptors are found in adipose 
tissue, the heart, and the lungs and cause an increased heart rate and force of 
contraction, bronchodilation, and lipolysis. Systemic blood pressure is increased by 
both alpha and beta receptor reactions by increasing the heart rate and contraction 
as well as vasoconstriction in the arterioles. These effects take place during 
sympathetic activity. During parasympathetic stimulation, the effects are the 
opposite. Many drugs have been used for both sympathetic and parasympathetic 
agonists and antagonists. The effects are mediated directly to the receptors or 
through sympathetic nerve endings, which in turn release NE to the receptors. 
(McCorry, 2007) 
In previous studies, sympathectomy has been associated with vessel 
supersensitivity to catecholamines, especially NE, causing excessive vasoconstriction 
in sympathectomized areas when compared with control areas. Sympathectomy 
stops NE release in the nerve endings, and leaves the NE receptors free for 
circulating NE. This has been thought to be the reason for abnormally high 
vasoconstriction. (Banbury, Siemionow, Porvasnik, Petras, & Zins, 1999a; Godden, 
Little, Weston, Greenstein, & Woodwards, 2000; Rizzoni et al., 2000) Lecoq et al. 
investigated the flap vessel vasoconstriction caused by denervation as in 
microsurgery. No signs of denervation-induced vasoconstriction were noticed. They 
also suggested that surgical sympathectomy might protect cutaneous flaps from the 
vasoconstriction induced by the release of endogenous catecholamines. (Lecoq, 
Joris, Nelissen, Lamy, & Heymans, 2008)   
According to Monroe et al., the risks of using vasopressors in free flaps seem to 
have been over emphasized. In the first of their two studies, they checked the patient 
records of 169 microvascular operations and found that vasopressors had been used 
in 82% of the operations intraoperatively “without permission”. Later, they allowed 
anesthesiologists to use vasopressors intraoperatively with no adverse effects 
noticed. (Monroe, McClelland, Swide, & Wax, 2010; Monroe, Cannady, Ghanem, 
Swide, & Wax, 2011) 
There seems to be four studies that aim to prove the safety of vasopressors in 
microvascular surgery for humans (Black et al., 2003; C. Chen et al., 2010; Monroe 
 38 
et al., 2010; Tuominen, Svartling, Tikkanen, & Asko-Seljavaara, 1997). Pattani et al. 
reviewed the literature on free flap complications. They found that intraoperative 
fluid administration, medical comorbidities, and prolonged operation time 
predispose patients to free flap disorders. However, no evidence supporting the 
hypothesis that free flap failure was caused by hypotension, colloids, and nitrous or 
vasopressor use was presented. (Pattani, Byrne, Boahene, & Richmon, 2010) 
Nevertheless, none of these nor most of the animal studies provided relevant 
information on the ideal therapeutic range of these vasopressors or the duration of 
safe administration (Ibrahim, Kim, Rabie, Lee, & Lin, 2014). 
2.4.3 Dopamine and dobutamine 
Dopamine is a sympathomimetic drug that has effects on organs that are clearly 
dose-dependent. A low dose selectively activates specific dopamine receptors, for 
example in the kidney, whereas a low dose has little or no effect on alpha or beta 
receptors. However, larger doses activate beta receptors more and result in 
vasoconstriction and increased heart rate systemically. (Koulu & Tuomisto, 2007) 
Dopamine has been used as a second option in treating hypotension after 
norepinephrine in patients with sepsis in the ICU (Rhodes et al., 2017).  
Dobutamine is an agent whose primary activity results from the stimulation of 
beta 1receptors of the heart, and it increases contractility and cardiac output. 
However, it also has weak beta 2 and alfa 1 activity. Moreover, it has inotropic effects 
on the heart, and it is less hypertensive than dopamine or NE. (Tuttle & Mills, 1975) 
In microvascular surgery, dopamine can cause vasoconstriction, and thus 
ischemia for free flaps. Three articles have been published on using dopamine in 
microvascular surgery. Both Cordeiro et al. and Suominen et al. measured direct 
arterial flow during operation simultaneously when dopamine was administered 
intravenously. (Cordeiro, Santamaria, Hu, & Heerdt, 1997; Singh, Fu Zhu, 
Dziegielewski, & Seikaly, 2012; Suominen et al., 2004) Similar results were reported 
with increased cardiac output after larger dopamine doses, but no increase in 
recipient flap artery flow. Cordeiro et al. stated that dopamine could be used with 
caution in free flaps, whereas Suominen et al. preferred dobutamine over dopamine 
should a vasoactive drug be needed. On the other hand, Singh et al. found high-dose 
dopamine safe in a rat model with no difference in free flap survival (dopamine vs. 
placebo) (Singh et al., 2012). In conclusion, in everyday clinical practice, both 
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dopamine and dobutamine could be used if a vasopressor or inodilator is required 
during or after microvascular surgery. (Suominen et al., 2004) 
2.4.4 Norepinephrine 
Norepinephrine (NE) affects both alpha and beta receptors causing increased 
peripheral resistance, and thus increased MAP. On the other hand, NE decreases 
heart rate refractorily. (Koulu & Tuomisto, 2007) In addition, NE affects 
sympathetic nerve endings both directly and indirectly. The former is caused by the 
direct effect of circulating the drug to the receptors in the sympathetic nerve endings, 
and the latter is caused by sympathetic nerve activation, which in turn causes 
norepinephrine to be released from its reserve inside the nerve. The latter could be 
blocked by denervation as happens in microvascular surgery, causing the denervated 
nerve endings to hyperreact to the circulating norepinephrine. This is supposed to 
cause stronger vasoconstriction than in sympathetically intact vessels, and it is 
thought to cause circulation problems for free flaps. Some experimental studies have 
shown catecholamines to cause excessive vasoconstriction in sympathectomized free 
flaps. (Banbury, Siemionow, Porvasnik, Petras, & Zins, 1999b; Godden et al., 2000; 
Rizzoni et al., 2000) These theoretic findings have led microsurgeons to be extremely 
careful when using norepinephrine with free flaps. However, previous clinical 
experience may suggest otherwise. Hiltunen et al. studied the effects of hypotension 
and its correction with NE intraoperatively in pig free flaps. They reported no 
adverse effects to the flap in the case of moderate hypotension or its correction by 
NE infusion, even with high doses. (Hiltunen et al., 2011) 
2.5 Postoperative sedation after microvascular surgery 
2.5.1 Background 
Standard postoperative sedation is achieved by using analgesics or sedatives. Many 
different drugs with different mechanisms, side-effects, and benefits are used. The 
main purpose of postoperative sedation in microvascular surgery is to ensure the 
vitality of the flap. However, a physician in the ICU should be careful not to increase 
patient morbidity or mortality and not harm the flap with the sedation instead. 
Fentanyl, morphine, and ketamine are the most used analgesic drugs. Midazolam, 
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propofol, and haloperidol are the most widely used sedative agents. No universal 
recommendation is available, so treatment protocols vary a great deal between 
different ICUs and different countries. (Liu & Gropper, 2003)  
There is growing evidence that too excessive sedation causes a lot of problems 
and leads to prolonged mechanical ventilation. However, inadequate sedation is also 
associated with risks, such as accidental extubation or restlessness, which is not 
optimal for free flap welfare. The goal of sedation should therefore be a tranquil and 
rousable patient. Hence, the level of sedation should be defined beforehand. It 
should be kept in mind, however, that there are some factors, i.e., bilateral neck 
dissection, massive blood transfusion, and a history of heavy smoking that support 
the use of more intensive sedation. (de Melo, Ribeiro, Kowalski, & Deheinzelin, 
2001; Jacobi et al., 2002; Mantz, Josserand, & Hamada, 2011) Lighter sedation often 
lowers costs during intensive care because of reduced length of stay and shorter 
mechanical ventilation times. (Dasta et al., 2010) 
Major reconstructive surgery, as in the operative treatment of head and neck 
cancers, is traditionally associated with a high postoperative risk for the patient and 
free flap survival. Therefore, these patients have generally been kept 
tracheostomized, sedated, and treated in the ICU for an average of 2 to 4 days. 
(Sigurdsson & Thomson, 1995; Spiegel & Polat, 2007) In the study by Spiegel and 
Polat, 88.9% of head and neck surgeons in the United States applied this protocol in 
2007.  
Although there are only a few papers that promote this kind of treatment 
protocol, it nevertheless seems to be more or less the “standard of care” (Arshad et 
al., 2014). Moreover, postoperative sedation prolongs hospital stay and increases the 
risk of pneumonia and use of antiagitative drugs (Allak et al., 2011). Ideally, a patient 
in the ICU should also be easy to arouse and be able to communicate the need for 
analgesia (Mantz et al., 2011). Therefore, recent guidelines prefer a light sedation 
associated with shorter ICU stay and fewer complications (Barr et al., 2013a). In 45% 
of US hospitals, the main reason for ICU treatment after microvascular surgery was 
a lack of adequately trained nursing personnel to control the status of the flap 
(Haddock, Gobble, & Levine, 2010). Nkenke et al. studied prospectively the 
differences between a special ward with specialized nurses and an ICU after head 
and neck surgery. They found no significant difference in ICU readmissions or flap 
survival between the groups. (Nkenke, Vairaktaris, Stelzle, Neukam, & St Pierre, 
2009) Similar findings have also been reported in other studies. Indeed, specially 
trained nurses and close medical support in an intermediate level ward seems to have 
similar results as treatment in an ICU (Morton, 2002; To, Tsang, Lai, & Chu, 2002).   
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The postoperative care of head and neck patients is under constant pressure to 
shift towards less costly treatments including less intensive care. However, to date, 
there have been no prospective and only a few studies that prove any difference in 
outcomes between normal ward and ICU treatment. (Dort et al., 2017; Morton, 
2002; Nkenke et al., 2009; To et al., 2002) Treatment in the ICU is quite expensive. 
For example, the price of a single day could be as much as 2000 to 3000 euros, which 
is much more expensive than in a normal ward, which is approximately 500 euros. 
As cost-effectiveness is considered to be more and more important, an increasing 
number of critical studies argue against routine postoperative sedation and treatment 
in an ICU. (Allak et al., 2011; Arshad et al., 2014; Nkenke et al., 2009; L. Setala et al., 
2009; Yu et al., 2018) In a recent survey in the United States, Kovatch et al. found 
that 75% of all head and neck free flap patients are still treated in an ICU for an 
average of 2 to 3 days. However, of these, only 11% needed postoperative sedation. 
Patient observation was mostly done on a clinical monitoring only basis, keeping in 
mind that there was on average 3 surgeons trained in microsurgery/institute. 
(Kovatch et al., 2018) 
2.5.2 Propofol 
Propofol is an intravenous anesthetic drug that is widely used for sedation during 
general anesthesia or as an induction agent for general anesthesia. As in many other 
anesthetics, the mechanism of action of propofol is poorly understood. It is, 
however, thought to be related to GABA-mediated chloride channels in the brain. 
Propofol has a few adverse effects with hypotension, caused by inhibiting 
sympathetic vasoconstriction, being the most important (Folino & Parks, 2017). 
During the intra- or postoperative period, this hypotension can cause a dilemma for 
anesthesiologists as to whether to use vasopressors or to use more IV-fluids. 
However, excessive amounts of both are potentially hazardous to the patient and the 
flap (Sigurdsson & Thomson, 1995).  
Barr et. al. reported that propofol accumulates unpredictably in some patients 
and leads to delays in extubation after postoperative sedation. They also found 
remarkable hypotension in 17% of their patients. However, when used carefully and 
the sedation level adjusted to need, propofol acted predictably. (Barr et al., 2001) 
Previous studies have reported that propofol affects blood coagulation by 
inhibiting blood clotting (Aoki, Mizobe, Nozuchi, & Hiramatsu, 1998; De La Cruz, 
Paez, Carmona, & De La Cuesta, 1999; Dogan, Ovali, Eti, Yayci, & Gogus, 1999; 
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Law, Ng, Irwin, & Man, 2001). Even though the effect of propofol on platelet 
aggregation appears to be clear, its effect on bleeding time has not been shown (Aoki 
et al., 1998). 
2.5.3 Dexmedetomidine 
Dexmedetomidine (DEX) is a highly specific alpha2 agonist used for sedation in the 
ICU. The alpha2 receptors are found in the central nervous system and in the spinal 
cord, where their activation lead to sedation and to some degree of analgesia by 
decreasing activity of noradrenergic neurons. DEX is as effective as propofol or 
midazolam in maintaining light postoperative sedation, but there has not been much 
evidence of its long-term safety.  (Ahmed & Murugan, 2013; Ebert, Hall, Barney, 
Uhrich, & Colinco, 2000; Iirola et al., 2012; Jakob et al., 2012; Nguyen, Tiemann, 
Park, & Salehi, 2017; Ruokonen et al., 2009; Venn, Hell, & Grounds, 2000)  
DEX seems to be ideal for light sedation with fewer analgesics needed. It 
produces a natural sleep-like condition from which patients can be easily aroused. 
(Nelson et al., 2003) Nevertheless, it does not cause sleep deprivation during 
sedation in patients in the ICU, which appears to lessen the risk of 
delirium.(Figueroa-Ramos, Arroyo-Novoa, Lee, Padilla, & Puntillo, 2009; 
Huupponen et al., 2008; Shehabi et al., 2009) This makes DEX even more suitable 
for head and neck postoperative follow-up because many patients have an increased 
risk of delirium due to heavy alcohol consumption and old age. In a large meta-
analysis, Peng et al. reported that DEX may reduce 30-day mortality, length of 
hospital and ICU stay, incidence of delirium, duration of assisted mechanical 
ventilation, risk of atrial fibrillation, and cardiac arrest (Peng et al., 2018). 
Alpha2 receptors are also found in blood vessels, where they mediate 
vasoconstriction, and in sympathetic nerve terminals, where they inhibit NE release. 
(Bloor, Ward, Belleville, & Maze, 1992; Drew & Whiting, 1979; Langer, 1980)  
DEX has dual cardiovascular effects. At low-plasma concentrations, it decreases 
MAP and heart rate, but at higher levels it deepens sedation and elevates MAP 
because of increased vascular resistance. (Bloor et al., 1992; Ebert et al., 2000; 
Keating, 2015) 
DEX is found to cause vasoconstriction in denervated vasculature, for instance, 
after microvascular surgery. (Bloor et al., 1992; Hogue et al., 2002; Talke et al., 2003) 
Used as a single sedative agent after reconstructive surgery, DEX yields higher 
systemic blood pressures compared with propofol and better perfusion pressures in 
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the transplanted flaps. To prove this hypothesis, Nunes et al. simulated the harvest 
of musculocutaneous flaps in twelve domestic pigs and monitored flap oxygenation 
and microdialysate metabolism during a postoperative sedation period. They 
reported that DEX increased systemic blood pressures by raising systemic vascular 
resistance, but it did not seem to have any negative impact on the local perfusion or 
viability of the denervated flaps. Tissue oxygenation and microdialysate metabolites 
did not differ between the study groups. (Nunes et al., 2007) 
In a recent study, DEX has also been found to attenuate the risk of blood 
coagulation after gastric surgery. It lowered fibrin degradation products and 
thrombin-antithrombin complex formation. The reason for this was thought to be 
lowered catecholamine levels which, in turn, inhibit platelet function. This finding 
was considered to be beneficial in preventing, for example, postoperative pulmonary 
embolisms. (Z. Chen et al., 2018) 
2.6 Theory synopsis 
Microvascular flaps are nowadays routinely used for reconstructions in head and 
neck cancer surgery. As previously noted, many flap monitoring systems have been 
described and are in varying degrees of use around the world. The pros and cons of 
each method and the reasons for using them are mainly based on the traditions of 
an institution or the personal opinion of an individual surgeon. Even the best 
monitoring system has limitations and confusing factors. Therefore, it is very 
difficult to set standards for the monitoring of free flap follow-up. Every patient and 
every flap must be taken as individuals with multiple confusing factors, leaving room 
for good clinical skills and assessment.  
The postoperative course of care is as crucial as operative techniques per se, while 
free microvascular flaps are vulnerable to vascular compromises. Therefore, optimal 
postoperative care that ensures flap survival and avoids re-operations is of the 
utmost importance. There seems to be no generally accepted gold standard for the 
ideal postoperative sedation, flap follow-up method, or postoperative medication. 
According to the current literature, most microsurgeons prefer ICU follow-up with 
sedation using propofol and avoiding the use of vasopressors. Flap follow-up is 
mostly done by clinical assessment together with hand-held Doppler ultrasound. 
During this study, the postoperative follow-up of head and neck free flap surgery 
at Tampere University Hospital was carried out in the ICU. Previously propofol was 
administered until the first postoperative morning. The aim was to have a MAP of 
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>70 mmHg. To reach this, anesthesiologists are nowadays allowed to use vasoactive 
medication if required, and only necessary fluids are administered. Previously more 
IV-fluids were used. Tissue oxygen levels were monitored using the Licox® 
monitoring system for more than 72 h postoperatively together with clinical signs of 
the flap confirming arterial pulsation using handheld Doppler when needed. In case 
of any doubt, an immediate re-operation and anastomosis revision was performed. 
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3 AIMS OF THE PRESENT STUDY 
The purpose of this study was to find out more about the optimal circulation and 
monitoring methods of free vascular flaps in head and neck cancer surgery 
The specific aims were as follows: 
1. To find out the tissue oxygen levels that indicate the circulation problems of 
free microvascular flaps, and to study the feasibility of tissue oxygen monitoring 
during the postoperative period after free microvascular flap surgery 
2. To estimate the role of microdialysate glycerol in tissue ischemia and the 
confounding effect of denervation in MD glycerol levels 
3. To find out whether or not the use of sympathomimetics or 
dexmedetomidine causes signs of vasoconstriction and flap ischemia during 
microvascular flap surgery in the head and neck area 
4. To compare propofol and dexmedetomidine postoperative sedation 
considering flap ischemia and survival in head and neck cancer surgery 
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4 MATERIALS AND METHODS 
4.1 Studies I-IV 
4.1.1 Study I 
In study I, the material comprised 118 head and neck cancer patients operated in the 
department of Otolaryngology, Head and Neck Surgery, Tampere University 
Hospital, Finland during the years 1999 to 2009. All patients underwent radical 
removal of the tumor and a selective neck dissection followed by a free flap 
reconstruction. (Table 1) In study I, the microvascular transfers were mostly radial 
forearm flaps (92), fibular (11), and scapular (3). A few other flaps were also used 
(Table1). A Licox® probe was inserted into the subcutaneous tissue or muscle before 
reconstruction and vessel anastomosis. 
Postoperative care was according to the usual protocol in the ICU, with no special 
requirements for medication. The analyses were made retrospectively based on 
medical records and PtiO2 monitor readings. 
Table 1.   . Patient demographics in studies I, III and IV 
  Study I Study III Study IV Together 
Patient demographics         
Sex M (F) 70 (48) 13 (12) 14 (6) 97 (66) 
Age (mean) 56 61 60  
Tumor site     
Oral cavity 84 14 13 111/163 
Oropharynx 24 11 7 42/163 
Hypopharynx 5   5/163 
Other 5   5/163 
Flaps     
Radial forearm flap 92 25 20 137/163 
Fibular flap 11   11/163 
Other flaps 15   15/163 
Re-operation 8 0 2 10/163 
M=male, F=female     
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4.1.2 Study II 
In study II, 12 domestic pigs were anesthetized and mechanically ventilated. Two 
identical rectus abdominis musculocutaneous flaps from both sides of each pig were 
raised by an experienced plastic surgeon. In A-flaps, the adventitia with its 
sympathetic nerves was carefully stripped from the artery. The adventitia in the B-
flaps was left intact. The flaps were then sutured in their original position and left 
intact during the experiment.  
Flap ischemia was induced by clamping both flap arteries for 60 minutes to mimic 
ischemia during a microvascular operation. (Figure 1) Ischemia was confirmed by 
measuring the tissue oxygen pressure of the flaps. The extracellular L/P ratio 
indicated the degree of anaerobic metabolism locally in the flap tissue. Thereafter, 
the flaps were followed carefully for the 60 minutes reperfusion period. 
 
Figure 1.  Study II protocol 
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4.1.3 Study III 
Study III comprised 27 consecutive head and neck cancer patients (15 oral, 12 
oropharyngeal). The patients were enrolled in an unblinded, randomized, controlled 
trial. Patient demographics are shown in Table 1. The patients were randomized in 
three groups of nine: NE, dopamine, and control group. Blocks of nine patients, 
three from each group, were used for the randomization, and the allocation was 
performed after the operation by the medical/research nursing staff in the intensive 
care unit. The patients were allocated into dopamine, norepinephrine, and control 
group for the postoperative period in the ICU. The groups were unblinded, so the 
ICU physician knew which drug had been given. In the control group, no medication 
was given unless MAP dropped below 60 mmHg. In the two medication groups, 
MAP was maintained between 80 and 90 mmHg with vasoactive drugs if needed. 
The medication used was determined according to the randomization protocol. 
All the operations were carried out using a two-team approach. An experienced 
head and neck surgeon performed the tumor removal, selective neck dissection, and 
reconstruction as well as microvascular anastomoses. A plastic surgery team 
harvested the flap simultaneously. Only radial forearm flaps were used. The 
microdialysis and Licox® catheters were inserted into the subcutaneous tissue side-
by-side and sutured or clipped in place before reconstruction. (Figure 2)  
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Figure 2.   Microdialysis (divided catheter) and tissue oxygen monitoring catheter sutured side by 
side in radial forearm flap 
 
The postoperative follow-up protocol was identical. (Figure 3) MAP, heart rate, and 
central venous pressure (CVP) were monitored and reported every hour. The levels 
of analgesic, sedative, and cardiovascular medications were followed.  
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Figure 3.   Study protocol in studies III and IV 
 
4.1.4 Study IV 
Twenty consecutive head and neck cancer patients were allocated in 2 equal groups: 
propofol group and DEX group. Blocks of four patients, two from each group, were 
used for the randomization and the allocation was performed after the operation by 
the medical/research nursing staff in the intensive care unit. The code of one patient 
had to be opened in the ICU, and therefore the groups were not equal in number.  
The operations, reconstructions, and postoperative follow-up protocol were 
identical to study III. 
Study IV had two groups: the DEX-group and the propofol group (control). The 
study was double-blinded, and the medication was administered by nontransparent 
IV-lines postoperatively in the ICU. The treatment group was sedated with DEX 
and the control group with Propofol as usual. Sedative agents were infused according 
to a six-step study protocol, which was also used in the Prodex study (Table 2) (Jakob 
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et al., 2012). Two pumps were used. One pump was used to administer saline-
placebo or propofol and the other to administer saline-placebo or DEX. Both 
pumps were adjusted simultaneously to ensure the medical personnel were unaware 
which medication was used. The sedation level was controlled hourly and, when 
necessary, changes to medication levels were made. 
 
 
 
Table 2.  The six dose levels of both medicines in study IV 
 
Dose Level Dexmedetomidine rate (ug/kg/h) 
Propofol rate 
(mg/kg/h) 
1 0.2 0.3 
2 0.45 0.8 
3 0.7 1.6 
4 0.95 2.4 
5 1.2 3.2 
6 1.4 4 
 
4.2 Tissue oxygen monitoring (Studies I-IV) 
Tissue oxygen was monitored with standard Licox® CC1.2 probes that were carefully 
inserted into the flap tissue via a standard catheter and secured with a clip or suture. 
The 2 cm long sensor area situated at the tip of the probe was confirmed to be wholly 
inside the flap, and thereafter the flap with a Licox® O2 probe was sutured into the 
proper place before anastomosis. The readings were displayed on a Licox®-device 
(Integra Life Sciences, Dublin, Ireland), and the data were automatically saved on to 
a linked laptop computer. The monitoring of the flaps was continuous. In the 
analysis, readings were taken at 2 to 3 hour intervals. The Licox® device was used in 
all four studies. 
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4.3 Microdialysis (Studies II-IV) 
MD catheters (20000 molecular weight cut off) were inserted into the tissue. Then, 
microdialysate was pumped through the catheter with a CMA100 microinjection 
pump at a constant speed of 0.1 μl/min.  The dialysate was collected in microvials 
and analyzed every 2 to 3 hours with microdialysis (CMA 600 Microdialysis Analyzer, 
CMA/Microdialysis AB, Solna, Sweden) devices. 
A commercially available metabolite kit (Iscusflex, Microdialysis, Solna, Sweden) 
was used for lactate, pyruvate, glucose, and glycerol analyses, and the readings were 
saved. L/P ratio as well as lactate/glucose ratio (L/G ratio) was calculated. 
MD was used in studies II, III and IV to investigate free flap extracellular fluid 
metabolism in order to observe any possible changes due to denervation or 
medication. Catheters were easy to insert in the flap tissue and the pump was easy to 
use. Microvials were collected and analyzed every 30 minutes in study II and every 
two hours in studies III and IV. 
The L/P ratio was considered to be the main variable in studies III and IV, with 
expected cut-off point at 20. As the L/P ratio showed unexpected variance and 
abnormally high levels in a clinical setting, the L/G ratio was also used in study IV. 
4.4 Ethics 
All the studies were approved by the Ethics Committee of Tampere University 
hospital. Study II was approved by the Ethics Committee for Animal Experiments 
at the University of Kuopio. Studies III and IV were also approved by the Finnish 
National Agency of Medicine. Study IV was also approved by European Clinical 
Trials Database (Eudra CT). 
 
4.5 Statistics 
Study I was retrospective, so all operated patients with relevant data were accepted. 
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In study I, the data were analyzed with receiver operating characteristics (ROC) 
analysis. In addition, negative and positive predictive values were calculated together 
with sensitivity and specificity. 
In study II, power calculation for sample size was not performed. Instead, a 
convenient sample size was chosen. The normality of the data was tested with 
Kolmogorof-Smirnof test (K-S test). T-test was used for all statistical analyses. 
Bonferroni correction was used due to multiple testing 
In studies III and IV, statistical power was calculated (80% power, α 5%) by using 
PS power and sample size calculator.  
In study III, data were analyzed by Wilcoxon and Friedmann and Mann-Whitney 
tests using SPSS (IBM SPSS Statistics, version 21). 
In study IV, linear mixed-effect models with L/P ratio, L/G ratio, or PtiO2 as 
dependent variables were fitted using function lme in R (Software environment for 
statistical computing and graphics, version 2.13.0, The R Foundation for Statistical 
Computing). Due to skewed distributions, natural logarithm transformation was 
applied for dependent variables.  
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5 RESULTS 
5.1 Studies I-IV 
 
5.1.1 Study I 
The Licox® monitoring method detected all cases with circulatory problems.  ROC-
analysis showed high negative predictive values and good efficiency for the alarming 
criteria to predict the need for a re-operation. There were no false negative cases in 
the whole material. The overall success rate with the reconstructions was 99.2% 
(117/118), and the salvage rate for the re-operated cases was 88% (7/8) (Table 3). 
Table 3.   ROC -analysis of PtiO2 -monitoring in 163 patients 
Alarm Re-operation    
  Yes No  Sensitivity 100%  
Yes TP=10 FP=14  Spesifity 92%  
No FN=0 TN=139  Positive predictive value 0.42 
Total 10 153  Negative predictive value 1 
TP/FP=True/false positive, TN/FN= true/false negative   
 
 
A typical PtiO2 curve shows a rapid response to the opening and closing of the 
artery during the vascular anastomosis phase of the operation (Figure 4). An average 
normal PtiO2 curve reaches a steady state within two hours postoperatively, followed 
by a slow descent. At the starting point, the mean readings were slightly higher in 
septocutaneous flaps than in muscular flaps - 75 mmHg vs. 52 mmHg, respectively. 
After 24 hours, the same readings were 60 mmHg and 40 mmHg, and at 72 hours 
36 mmHg and 30 mmHg, respectively (Figure 5).  
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Figure 4.  Typical PtiO2 -curve during arterial and venous anastomosis. Arrows indicate the 
unclamping (1st and 3rd) and clamping (2nd) of the artery. 
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Figure 5.  Mean PtiO2 -levels in 118 patients. Black line shows constantly lower values in muscular 
flaps in comparison with subcutaneous flaps (grey line) 
In twenty-one patients (18%), there was a clear change in the trend of the curve, 
a decline of 50% in less than an hour or a decline below 10 mmHg in the PtiO2 
readings (Table 3). After subsequent analysis of the flap's clinical signs, a decision to 
re-operate was made in 8 cases. Thus, 13 / 21 (62%) of the alarms were false positive. 
Six patients were operated during the first 24 hours and two during the first 72 hours. 
Two patients had to be re-operated twice. One flap did not survive and had to be 
replaced with a new one. In 7 patients, a venous blockage occurred due to a 
compressing hematoma, and there was one arterial thrombosis. A typical curve 
leading to a re-operation caused by a venous blockage is shown in Figure 6. 
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Figure 6.  Typical PtiO2 -curve with venous thrombosis with a noticeable angle in the curve leading to 
a decrease close to 0 mmHg 
 
5.1.2 Study II 
In study II, MD-glycerol was measured and analyzed in both denervated and intact 
flaps. After 60 minutes of ischemia, a significant increase in levels of MD glycerol 
was noticed in both denervated subcutaneous and intramuscular flaps (P=0.0002 
and P=0.016, respectively) and in neurologically intact subcutaneous and 
intramuscular flaps (P=0.0002 and P=0.0002, respectively). There was, however, no 
significant difference between these groups (Figure 7). Also, subcutaneous and 
intramuscular glycerol levels reacted equally. The reason for the elevated MD 
glycerol levels of the flaps was tissue ischemia and an early phase of flap necrosis 
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independent of whether the sympathetic innervation was removed or left intact. No 
sign of possible confounding effects of sympathetic stimulus was observed. 
 
Figure 7.  No statistical difference was seen in MD -glycerol levels between flaps with intact 
enervation and denervated flaps (Study II) 
The elevation of MD glycerol was also observed in one patient in study IV as a 
marker of the cell destruction during ischemia shown in Figure 8.   
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Figure 8.  PtiO2 (mmHg) and MD -metabolites in a patient with two re-operations. In L/G and L/P -
curves, the two peaks can be easily noticed. MD -glycerol (μmol/L) also started a steep 
incline showing an imminent flap loss. However, the second re-operation was successful. 
5.1.3 Study III 
In study III, 25 patients were analyzed. Of these, 9 belonged to the norepinephrine 
group, 8 to the dopamine group, and 8 to the control group. All operations and 
postoperative recoveries in both the intensive care unit and a normal ward were 
uneventful. No flap losses or major complications leading to re-operations in any of 
the groups were observed. The number of drugs used in the study are shown in 
Table 4. 
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Table 4.   The amount of vasoactive medication given in study III. 
Study group  Vasoactive drug MAP (mmHg) HR 
    
Norepinephrine n=9 Levophed 9.8 mg (3-21) 83(±2) 73(±9) 
Dopamine         n=8 Abbodop 558 mg (144-1710) 79(±7) 86(±20) 
Control               n=8  
Levophed  2.9 mg (1-4)*  
Abbodop 8.8 mg** 
82(±8) 89(±15) 
    
* 3 patients  
   
** 1 patient 
  
     
 
Heart rate, CVP, and MAP are shown in Figure 7. MAP measurements showed 
the most stability in the norepinephrine group. The dopamine group had the greatest 
variation in MAP levels and heart rate (Figure 9). 
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C. 
 
Figure 9.  Mean values of A) CVP (mmHg), B) Heart rate, and C) MAP (mmHg) in different groups 
shown in study III. 
 
In the control group, three out of eight patients required small amounts of both 
vasopressor agents to maintain the pre-set MAP levels >60 mmHg (Table 4). 
 
The L/P ratio and PtiO2 measurements showed a similar pattern in all study 
groups (Figure 10). The behavior of these values was similar in all three groups 
during continuous monitoring for 72 h. No significant differences in partial tissue 
oxygenation and L/P ratio levels at any time-point between the NE and dopamine 
groups were observed.  
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B 
Figure 10.  In study III, the different study groups are shown in A: MD -L/P -ratio and B: PtiO2 
 
 
5.1.4 Study IV 
In study IV, 20 patients were divided into a propofol group (n=9) and a DEX group 
(n=11) (Table 5). Their hemodynamic parameters were monitored during 
postoperative sedation and they remained similar (Figure 11). Richmond agitation 
sedation score (RASS-scores) were also identical, indicating adequate sedation. In 
the propofol group, the patients tended to need a little more of the rescue medicine 
midazolam and equal amounts of analgesic agents during sedation (Table 6).  
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Table 5.  Patient demographics in study IV 
 
 
 
 
 
 
  
 Propofol-group Dex-group 
Patient demographics 7 6 
Oropharyngeal cancer, n 2 5 
Age, mean, y 60 (21-77) 60 (26-82) 
Sex (M/F),  (7/2) (7/4) 
Apache, median 14 14 
SOFA, median 5 5 
Sedation time, median, h 15 14 
Lactate highest during sedation, median 1,4 1,2 
Diuresis, median ml/kg/h 1,2 1 
n=number, y=years, h=hours, SOFA=sequestial norgan failure 
assesment    
Apachce=Acute physiology age and chronic health evaluation score   
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C 
Figure 11.  Level of sedation and hemodynamic parameters in study. IV A) RASS -score, B) CVP 
(mmHg), C) MAP (mmHg)  Dex=dexmedetomidine, Propo=propofol 
Table 6.  Amounts of rescue medicine in study IV 
Medication Propofol-group Dex-group P-value 
Propofol, mean, mg/kg/h 22 0   
Dexmedetomidine, mean, μg/kg/h 0 1.3   
Midazolam, mean, μg/kg/h 17 12 0.63 
Dormicum, mean, μg/kg/h 10 9 0.98 
Fentanyl, mean, μg/kg/h 0,53 0,56 0.89 
Norepinephrine, mean, μg/kg/h 2.4 1.8 0.49 
 
No significant difference was observed in either PtiO2 or L/P and L/G values 
between the groups. In other words, no signs of untoward vasoconstriction in the 
flaps (Figure 12). Altogether, all flaps were successful. There were two re-operations 
due to hematoma in the propofol group with a 100% salvage rate. These results show 
that DEX is comparable with propofol in the postoperative sedation of head and 
neck free flap patients. 
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Figure 12.  No statistical difference was shown in A) L/P-ratio B) L/G-ratio and C) PtiO2 between DEX 
and Propofol in Study IV.  
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5.2 Free flap monitoring methods 
5.2.1 Tissue oxygen monitoring 
PtiO2 monitoring with the Licox® system was used in all the present studies. In 
clinical studies (I, III, IV), the system detected all the vascular compromises, i.e., 10 
of 163 patients (Table1). One flap was lost, resulting in a total free flap survival rate 
of 99.4% and a salvage rate of 90%. The Licox® system alarmed the surgeon 
beforehand in every case, leading to revision with a sensitivity of 100% (Table 3) 
with a typical curve (Figure 6). One re-operation was performed because of a large 
hematoma with no ischemia signs in the PtiO2 curve. This was detected during a 
routine clinical follow-up visit by the surgeon and evacuated. In the re-operation, no 
signs of vascular compromise were observed. In other words, the flap circulation 
was still working, and the hematoma was successfully evacuated before it caused any 
ischemia to the flap. Therefore, this case was not considered a real true negative. The 
sensitivity of the Licox® system was 90% with a total of 14 false alarms, which were 
confirmed by clinical observation and meticulous clinical follow-up. No flap losses 
or even re-operations happened due to a vascular compromise which was not seen 
in the tissue oxygen pressure curve, yielding a false negative rate of zero. 
In study II in an experimental animal setting, PtiO2 readings reacted to a clamped 
artery (total ischemia) as expected. At the baseline, the mean PtiO2 reading was 20 
mmHg, decreasing to 5 mmHg and 0.5 mmHg after 30 minutes and 60 minutes, 
respectively (Figure 13). This is precisely similar with the curve seen normally in 
microvascular operations when an artery is clamped for any reason. (Figure 4)  
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Figure 13.  The PtiO2 -readings together with L/P -ratio are shown during clamp induced ischemia in 
study II 
 
In studies II to IV, the Licox® system was used together with MD to double 
check the outcome of the flaps during the administering of the study drugs in the 
ICU. Both methods adequately reacted to flap problems: the Licox® system noticed 
ischemia, and MD confirmed a shift from aerobic to anaerobic metabolites in the 
extracellular fluid (Figure 7). 
5.2.2 Microdialysis 
5.2.3 Lactate/pyruvate-ratio 
The lactate/pyruvate ratio was used as the main variable to express ischemia in our 
hypothesis. In studies III and IV, its values were higher than the expected range 
(>22-25) but remained constant throughout the observation period (Figure 8). As in 
PtiO2 monitoring, the trend seems to be a mild downwards shift after operation.  
Figure 8 shows the L/P curve together with the PtiO2, glycerol, and 
lactase/glucose (L/G) curve in a re-operated patient, and all of these reacted to 
ischemia as expected. The L/P ratio and the L/G ratio were elevated, and the PtiO2 
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curve approached zero. The L/P curve seems to react quickly to ischemic changes, 
indicated by the arrows, but also remained high after the first re-operation. 
Evacuating the hematoma and re-anastomosing the vessels in a re-operation 
eventually saved the flap. 
In a controlled animal setting in study II, the L/P ratio quickly reacted as 
expected, rising significantly high after clamping, and therefore led to total ischemia 
(Figure 12). However, no absolute alarm limits can be given according to the findings 
of this study. 
 
5.2.4 Lactate/glucose-ratio 
In studies III and IV, the L/G ratio was found to be more stable than the L/P ratio, 
still reacting to ischemia precisely. In a re-anastomosed flap before vascular 
compromises, the L/G ratio was constantly below ten (Figure 6), but when problems 
with circulation appeared, it increased tenfold or even more. Even though no 
absolute alarm limits could be given, the trend of the curve should be taken into 
account. 
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6 DISCUSSION 
6.1 General discussion 
Patients undergoing ablative and reconstructive head and neck surgery are treated 
with free microvascular flaps, which have almost entirely replaced pedicled flaps. 
Free flaps are used in the reconstruction of defects and to restore functions, such as 
chewing, speaking, and swallowing. Nowadays, there are more indications for free 
flaps other than malignancies, and the number of head and neck cancer patients is 
increasing all the time. Hence, free flap reconstructions are performed more and 
more frequently. There are several different transfers available ranging from soft 
tissue flaps to composite structures. However, in a single institution only a few of 
them are routinely used, although individualized treatments with various different 
flaps have been found feasible (Husso et al., 2016; Steel & Cope, 2015). In the 
present study, septocutaneous radial forearm flaps were mostly used, but also a few 
osseomuscular fibula and scapula flaps and musculocutaneous ALT-flaps. Normally, 
the flap tissue is totally dependent on only one artery and one or two veins. This 
makes flaps susceptible to vascular problems during the first postoperative days. 
According to the literature, a meticulous microvascular technique, an optimized 
postoperative setting, and follow-up with timely re-operation to save the flap are the 
key reasons for the current flap success rate of over 95%, as was also seen in the 
present study. Yet, flap failure leads to re-operation, prolongs hospitalization, and 
increases both patient morbidity and costs. (Cervenka & Bewley, 2015) 
6.1.1 Free flap postoperative follow-up 
 
Even though the free flap success rate is high, the need for reliable postoperative 
monitoring during the first postoperative days, which are the most critical for free 
flap survival, is widely accepted. Clinical follow-up together with a hand-held 
Doppler device is considered to be so effective that it is not possible to achieve better 
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results using other monitoring methods. However, this method demands hourly 
bedside visits during the first days and is therefore time consuming. Therefore, it is 
not ideal for smaller hospitals. (Cervenka & Bewley, 2015; D. Chubb et al., 2010) A 
reliable monitoring system reduces the need for regular routine check-ups. As 
reported in the present study, the most remarkable practical advantage of using the 
Licox® PtiO2 monitoring system is the possibility to lessen the need for continuous 
clinical follow-up of the flap during the immediate postoperative period. Instead of 
having the surgeon regularly checking for clinical signs during the first 72 
postoperative hours, nurses can easily monitor continuous real-time data on blood 
circulation in the flaps and only alert the surgeon if needed. 
Many different monitoring methods are presented in the literature, although 
some are more suitable for free flap monitoring than others. All of these methods 
have pros and cons, and there is a learning curve for each method in interpreting the 
results. As seen in the literature and in this study with PtiO2 monitoring and MD, 
after the proper learning level has been reached, all of the methods are suitable for 
the monitoring of free flaps. However, the possibility of false alarms should be kept 
in mind. The choice of flap monitoring method depends on the subjective opinion 
and previous experience of the surgeon as well as the availability of the different 
methods. (Abdel-Galil & Mitchell, 2009a; Abdel-Galil & Mitchell, 2009b; Cervenka 
& Bewley, 2015; Kaariainen et al., 2018) 
The cost-effectiveness of a monitoring system is a complex equation of hospital, 
operating theatre and monitoring costs. In Tampere University Hospital an average 
cost of an ICU-treatment is 2000€/day, which is four-times more than treatment in 
normal ward. During this study the prices for both the PtiO2 monitoring probe and 
MD-analyzers was around 500€/patient. In this study both were used so the cost for 
one patient was ca. 1000€. In previous literature the cost of an implantable Doppler 
probe was 275€ (Rozen, Chubb, Whitaker, & Acosta, 2010) and clinical monitoring 
193€ /patient (Subramaniam et al., 2016). In Tampere University Hospital the cost 
of an operating theatre is around 700€ an hour. Normally the re-operation leads to 
multiple extra ICU-days and several hours in operating theatre with a total cost of 
minimum 5000€. If the flap is lost a new flap is usually used, meaning total costs of 
15000€, with new microvascular operation, ICU-days and prolonged treatment in 
normal ward. Although the free flap success rate is high, one must consider the 
salvage rate being more important in calculating cost-effectiveness because with a 
successful salvage estimated 10000€ could be saved. It can be estimated that 
monitoring is cost effective if at least one out of 20 flaps (5%) can be salvaged with 
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a 500€ monitoring cost/ flap. In this study the salvage rate is 9 out of 163 (5,5%), 
therefore in our series the PtiO2 monitoring can be considered cost-effective. 
Nevertheless, when the monitoring methods fail, the surgeon still has the 
possibility to use clinical evaluation based on the color and turgor of the flap together 
with a needle pinprick test. Moreover, this type of evaluation is still thought to be 
the gold standard or at least the closest to it in free flap follow-up (Abdel-Galil & 
Mitchell, 2009a; Abdel-Galil & Mitchell, 2009b; Cervenka & Bewley, 2015; Chae et 
al., 2015; D. Chubb et al., 2010). This was also the case in the present study. When 
PtiO2 monitoring alerted the surgeon in charge, the final decision whether to re-
operate or not was based on additional clinical evaluation, if possible. 
Flaps can be monitored in many ways. The basic method is hourly clinical 
observation by nurses, who alert the surgeon in charge when something may already 
be wrong in the flap. More advanced methods are able to predict that something is 
about to go wrong. However, closer and more advanced monitoring requires more 
sophisticated devices and a lot of experience. For example, Setälä and Gudaviciene 
analyzed 268 flaps with MD lactate, glucose, and L/G ratio and found out how 
patient temperature changes or degree of vasoconstriction showed minimal signs of 
ischemia in the flap and still did not affect its outcome (L. Setala & Gudaviciene, 
2013). In the present study using PtiO2 monitoring, there seem to be flaps that tend 
to have low O2 readings but have no clinical signs of flap failure. Thereafter, the 
levels return to normal without any noticeable specific reason. This could be a sign 
of minor problems in flap perfusion, as observed in Setälä’s study. In these cases, 
the decision whether to re-operate or merely observe requires special expertise. In 
other words, to decide whether a flap perfusion failure is going to lead to inevitable 
flap loss or is only a temporary disorder. 
6.2 Studies 
6.2.1 Study I 
Study I is a retrospective analysis of 118 head and neck reconstructions operated at 
Tampere University Hospital since the year 1999. The main finding in the study was 
that the Licox® PtiO2 monitoring system is a good postoperative monitoring method 
that helps to achieve a free flap success rate of 99%. During the study period, only 
one flap was lost, although eight re-operations were performed. This result is slightly 
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better than reported in the previous literature with different monitoring methods 
(Disa et al., 1999; Hidalgo et al., 1998; Spiegel & Polat, 2007).  
The PtiO2 values are shown on a monitor from which the trend of the curves can 
be seen. Although the Licox® probe is easy to insert into the flap, the meticulous 
insertion and fixing of the probe are also highly important. Indeed, before carefully 
suturing the probe, a few were accidentally dislocated. Moreover, in the beginning, 
some patients managed to bite the probe. Later, the probe was inserted in such a 
way that made this impossible. 
Tissue oxygen tension of a free flap follows a typical curve during and after the 
operation. Usually, after arterial anastomosis is accomplished and the clamp opened, 
there is an immediate rise in oxygen pressure. After a few hours postoperatively, the 
levels reach their steady state and start to slowly decline during the following days. 
In this study, the reactions of the PtiO2 curve were similar to the ones reported in 
previous studies. (Hirigoyen et al., 1997; Jonas et al., 2013) 
High readings immediately after surgery may be due to ischemia and local 
microtrauma, which damages the mitochondria of the cells and results in high 
extracellular O2 concentrations. However, these readings can also be explained by 
the fact that the afferent artery is a branch of the carotid artery and produces a high 
volume of arterial blood into the flap tissue.  During the first two postoperative 
hours, it is not uncommon to notice a slight dip in the in PtiO2 levels, which is 
probably due to the tissue edema in the flap. Later, the PtiO2 levels stabilize and reach 
a steady level. Since the system reacts rapidly to changes in PtiO2 levels, any possible 
ischemia is naturally detectable also during this stabilization period. During the 
following 72 hours, the readings start to slowly decline even without any circulatory 
problems. This decline is due to tissue autoregulation that is thought to be caused 
by both circulating metabolites and the vasoconstriction of the flap arterioles (Morff 
& Granger, 1982). 
When this study started, there were only rough alarming limits for imminent 
ischemia, and the trend of the curve together with clinical check-up was considered 
more important than single readings. Based on the results of the present study, alarm 
limits could be set so that a 50% drop in PtiO2 readings or a simple drop below 10 
mmHg with no spontaneous recovery in 30 minutes predicts vascular problems. 
These flaps should be meticulously controlled and re-operated if no spontaneous 
recovery occurs. These findings are similar to those previously published in the 
literature. (Hirigoyen et al., 1997; Hofer et al., 1993; Kamolz et al., 2002) 
According to the findings of the current study, the Licox® PtiO2 monitoring 
system can be used as an alarming monitoring system for microvascular free flaps. 
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The system identifies imminent ischemia early enough and appears to be as useful as 
expected based on previous clinical experience (Kamolz et al., 2002; Raittinen et al., 
2005). The main disadvantage of this method mentioned in previous studies is the 
number of false positives caused by technical problems (Jonas et al., 2013). In this 
material, the reason for the relatively high number of false positive alarms seems to 
have been the high sensitivity of the probe to movement and mechanical 
manipulation.  
It is important to understand the importance of false alarms for overall flap 
survival: a false positive result may lead to unnecessary revision, while a false negative 
will lead to flap failure. Since the specificity of the system is 88%, one has to 
acknowledge that this system is not an absolute monitoring system but an alarm 
system that still requires clinical observation and decision making. However, it 
should be pointed out that all false alarms were false positive, and thus this makes 
the system highly sensitive to any actual circulatory problems. The fact that the 
system has good specificity, i.e., no false negatives occurred, is one of the best 
features of PtiO2 monitoring. This was observed in the present study as well as in the 
study by Arnez et al. (Arnez et al., 2018)  
6.2.2 Study II 
MD-glycerol has been used as a marker of disintegrating cell membranes. However, 
lipolysis only, as induced by sympathetic stimulus, may increase the extracellular 
concentration of glycerol. Thereby, variation in sympathetic drive is potentially a 
confounding factor for glycerol as a marker of ischemic cell membrane 
disintegration. Surgical procedures cause lipolysis either due to ischemia or 
sympathetic stress. (Arner, 1988; Fellander, Nordenstrom, Tjader, Bolinder, & 
Arner, 1994; Rojdmark et al., 1998) The main finding of study II was the opposite 
to the original hypothesis, i.e., intact innervation of the microvascular flap did not 
contribute to intramuscular extracellular glycerol release as compared to denervated 
flap after 60 minutes of ischemia.  
Sympathetic stress or tissue destruction are thought to be reasons for elevated 
extracellular glycerol levels in free flaps.(Fellander et al., 1996; Udesen et al., 2000) 
In the present study, the MD-glycerol levels were identical both in denervated flaps 
and in flaps with intact sympathetic innervation. This led to the conclusion that 
sympathetic innervation does not interfere with MD glycerol levels, leaving ischemic 
damage as the only reason for elevation in MD glycerol concentrations. 
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Therefore, MD glycerol may add to the diagnostics of a tissue perfusion defect 
indicated by low PtiO2 and high L/P ratio equally in free microvascular flaps and 
pedicled flaps with intact innervation. Thus, a stepwise diagnostic approach is 
possible, where low PtiO2 indicates early perfusion (O2 supply) failure, an increasing 
L/P ratio confirms metabolic derangement, and an increasing glycerol concentration 
indicates cell injury related to ischemic conditions has already started.  
Study II was done under strict laboratory conditions, which makes it easily 
repeatable. There were two different flaps in the same animal serving as a control 
group for each other. A small sample size with no power calculated and 
randomization could be considered as a minor weakness of this study.  
6.2.3 Study III  
Head and neck cancer patients who undergo tumor ablation and microvascular 
reconstruction often experience systemic changes due to prolonged major surgery 
with tissue trauma, fluid loss, and possible hypothermia. This is one of the reasons 
for intensive postoperative care and even sedation. Sedatives have a tendency to 
cause hypotension and sometimes lead to a need for corrective actions.(Barr et al., 
2001; Bloor et al., 1992; Ebert et al., 2000) The control of intra- and postoperative 
blood pressure and the avoidance of hypotension is a determining factor for 
adequate microvascular flap perfusion. If the need to elevate MAP occurs, the 
clinical dilemma exists between anesthesiologists and microsurgeons as to whether 
to add circulating plasma volume or to use vasopressors to improve cardiac output, 
which in turn may cause unwanted vasoconstriction. (Gooneratne et al., 2013; 
Kovatch et al., 2018; Sigurdsson & Thomson, 1995) A recent Finnish 
recommendation suggests the clinical judgement of the liquid balance and possible 
repair primarily with vasopressors to increase MAP. Extra fluids should be 
considered later according to secondary judgement together with inotropes. 
(Wilkman & Kuitunen, 2018) 
Autonomic nerve fibers running along the anastomosed vessels are disrupted in 
microvascular surgery, which changes the response of the vasodilated flap vessels to 
vasopressors. This phenomenon is significant and emphasizes the importance of 
studying metabolic and circulatory changes in the flap itself during treatment with 
different vasopressors. The results of recent studies measuring graft blood flow 
together with the results of the present study indicate that the vasoconstrictive effect 
of systemically administered norepinephrine in denervated flaps is markedly 
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attenuated in the acute phase after microvascular reconstruction (Eley, Young, & 
Watt-Smith, 2012). A lack of denervation-induced hypersensitivity to 
vasoconstriction produced by α-adrenergic agents is also observed in pedicled grafts 
(Lecoq et al., 2008).  
Ibrahim et al. reviewed four human studies of vasopressor use in free flap surgery. 
None of them showed any significant adverse reactions. According to the present 
and previous studies, there seems to be no evidence that vasopressor use should be 
contraindicated. However, the majority of the literature supports limited and careful 
use of vasopressors in microvascular surgery. (Ibrahim et al., 2014)  
These findings also support the safe use of norepinephrine and dopamine as 
vasopressors if necessary, at least during the first 72 h after microvascular 
anastomosis. MAP was successfully increased with both agents. The PTi02 and L/P 
ratio values in the flaps did not significantly differ among the norepinephrine, 
dopamine, and control groups. These results provide further evidence that the use 
of norepinephrine and dopamine to maintain sufficient MAP does not have adverse 
effects on free flap metabolism and circulation. The results indicate that 
norepinephrine and dopamine may be safely used during the immediate 
postoperative period after reconstructive head and neck microvascular surgery using 
the radial forearm flap. However, dopamine doses must be significantly higher to 
maintain an optimal MAP, and therefore the risk of side effects is greater, and 
dopamine should be used with caution.   
Study III was prospective and randomized but not blinded. The nature of the 
study was intention-to-treat, so the amount of vasoactive medication varied between 
patients, which can be considered a minor weakness of the study. However, in 
routine intensive care, the amounts have to be titrated individually taken into account 
patient weight and response, etc. The results of the present study only apply to head 
and neck patients undergoing reconstruction with radial forearm flaps. Further 
research should be carried out to study the effect of vasopressors on perforator flaps 
and in other anatomical areas, such as the lower limbs, to support its generalized use. 
MD has been used to measure numerous metabolites and even drug 
concentrations in different tissues, e.g., blood and brain. It also seems to be useful 
as a postoperative monitoring system for free flaps.(Edsander-Nord et al., 2002; 
Jyranki et al., 2006; Nielsen, Gutberg, & Birke-Sorensen, 2011; L. Setala et al., 2006) 
The MD pump could be set in advance to the desired speed and during monitoring 
only microvials are sampled and analyzed. In a free flap follow-up, the suggested 
monitoring interval is hourly in the first postoperative day, every 2 hours on the 
second day, and every 3 hours on the third day.(Jyranki et al., 2006; L. Setala et al., 
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2006) In this study, MD was used together with PtiO2 monitoring, which gives 
continuous information about the flap. MD was found to be slower to react to 
ischemia than PtiO2 levels. Similar findings have been published previously with 
implantable Doppler, which also detects the flaps continuously (Frost et al., 2015) 
6.2.4 Study IV 
In these studies, we have observed that external manipulation of the probe triggers 
immediate changes in the subsequent PtiO2 readings. Suctioning, restlessness of the 
patient, or manipulation of the reconstruction can cause a sharp temporary rise or 
decline in the curve. It has been found to be beneficial to keep the patient under 
sedation for the first 12 to 18 postoperative hours and to try to minimize mechanical 
manipulation of the reconstructed area. In the early part of this series in study I, 
variation in the PtiO2 curves, caused by the previously discussed reasons, quite 
understandably resulted in several alarms. These problems seem to relate to the 
clinical surroundings. No problems occurred in study II conducted under strict 
laboratory conditions with no movement of the animals, and therefore no 
malfunction of the PtiO2 probe. This finding supports the assumption that 
restlessness and movements of the patient could dislocate or even break the probe. 
Therefore, the proper postoperative setting with optimal sedative medication is 
important not only for the survival of the flap but also for the success of the PtiO2 
monitoring.  
The American College of Critical Care Medicine recommends the use of non-
benzodiazepine sedatives, such as propofol or DEX, in the ICU (Barr et al., 2013b). 
Propofol is traditionally used for sedation together with midazolam boluses. 
However, recent studies have shown that DEX could also be feasible in short term 
sedation.(Barr et al., 2013a; Martin, Ramsay, Mantz, & Sum-Ping, 2003) There seems 
to be neither consensus nor ideal agent for moderate sedation. However, it should 
be rapid in onset, have a predictable pharmacodynamic profile, and it should allow 
quick recovery of the cognitive and physical functions of the patient.(Gan, 2006) As 
a postoperative sedative, DEX offers a few advantages compared with propofol. 
These include shorter ICU and mechanical ventilation time due to lighter sedation, 
fewer analgesics needed, and lower postoperative delirium risk. DEX is also more 
cost-effective than midazolam.(Bloor et al., 1992; Dasta et al., 2010; Ebert et al., 
2000; Keating, 2015; Shehabi et al., 2009; Talke et al., 2003) The better analgesic 
feature of DEX was not, however, observed in the present study. DEX is superior 
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not only from the clinicians’ but also from the patients’ point of view, causing less 
anxiety than propofol during ICU stay (Venn & Grounds, 2001) .  
 
Flap complications due to uncontrolled vasoconstriction in denervated vessels 
are a concern during DEX sedation (Bloor et al., 1992; Talke et al., 2003). 
Nevertheless, the present study indicates that DEX is an ideal drug for the 
postoperative sedation of head and neck microvascular patients. No sign of flap 
vasoconstriction with ischemia was observed in the present study and in a previous 
animal study with free flaps.(Nunes et al., 2007) Study IV was randomized, double 
blind, and double dummy making it easily repeatable.  
Previous studies have reported that propofol also has an effect on blood 
coagulation, yet no effect on bleeding time has been shown (Aoki et al., 1998; De La 
Cruz et al., 1999; Dogan et al., 1999; Law et al., 2001). A similar effect was also 
observed with DEX in a study by Chen (Z. Chen et al., 2018). In study IV, two 
bleeds (one from the pedicle artery branch and one from the facial artery branch) 
occurred in the propofol group, whereas none occurred in the DEX group. Whether 
this was just coincidence or caused by propofol per se remained unclear.  
According to the present studies, strict guidelines for MD values cannot be given. 
Setälä et al. used glucose level <2 mmol/l, lactate >6 mmol/l, and an L/P ratio of 
more than 25 as alarms to the microsurgeon.(L. Setala et al., 2006) In Jyränki’s study, 
the L/P ratio never exceeded 25 in a successful flap.(Jyranki et al., 2006) In studies 
III and IV, the L/P ratio was higher than 25, but no flap failures or even circulatory 
problems were found. The lactase/glucose (L/G) curve seemed to be more 
consistent, yet in this study there were not enough patients or true flap failures to 
give exact limits for the readings. The trend of the curve should be checked, and a 
significant increase should be seen as an alarm signal indicating circulatory problems.  
In study IV, one patient had to be re-operated because of a hematoma, and the 
PtiO2 and MD curves are shown in Figure 8. Here, the differences in L/P and L/G 
ratios are shown. Both react accurately to the first signs of ischemia; however, the 
L/P ratio remains higher after the first ischemic period while the L/G ratio is rapidly 
normalized back to the original level. Prolonged elevation of lactate after ischemia 
has been detected previously (Edsander-Nord et al., 2002). However, the reason why 
a difference in L/P and L/G ratio was observed in this study remains unclear. The 
reason could be a slower increase in pyruvate levels, which is a metabolite of glucose, 
and therefore its levels depend not only on the level of glucose but also on whether 
there are aerobic or anaerobic circumstances in the tissue.  
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6.3 Future applications 
6.3.1 Free flap monitoring 
Considering the difficulties in the field of free flap monitoring, tissue oxygen 
monitoring with the Licox® PtiO2 monitoring system seems to be useful method. 
Moreover, the small size of the equipment makes it easy to use bedside in even 
smaller patient rooms. The trend of the curve is visible, and alarms can be set to 
notify the staff of circulatory compromises. The alarm limits shown in study I help 
the nursing staff and novices to notice problems while more experienced users look 
at the trend of the curve rather than simple limits. Therefore, it would be optimal 
that someday the PtiO2 readings could be sent to a mobile app to ease the work load 
of the surgeon in charge. However, to make it more useful in everyday practice, the 
learning curve of the system should be easier, and the costs should be a lot less than 
they are now.  
MD alone as a postoperative monitor is also feasible, but some extra criteria 
should be fulfilled. The monitor needs more space, and it is not easily moved. 
Subsequently, the equipment must be apart from the patient room requiring extra 
personnel to interpret the analysis. However, the system per se is much more 
informative in free flap follow-up than a simple Doppler or PtiO2 monitor. The 
system provides exact metabolite information at half hourly intervals and, according 
to the present and previous studies, even hints of imminent flap disorder due to the 
elevation of MD glycerol levels. One of the extra advantages of MD is the possibility 
to monitor several other molecules, such as drug levels in the flap, which could, for 
example, be used in clinical studies.  
There seems to be room for both PtiO2 monitoring and MD. Both monitoring 
methods allow easy monitoring by nurses and lessen the control visits of the surgeon 
from. Furthermore, as shown in these studies, both can also be useful in clinical 
experiments. 
Perhaps in future, these two monitoring systems could be used together in 
hospital to provide more accurate data on the status of the flap. For example, the 
PtiO2 monitor would follow the oxygenation continuously, and if there is a suspicion 
of a decline in levels, this could be confirmed with MD. A decline in glucose and 
pyruvate levels together with an elevation in lactase and glycerol levels should be 
noticed. If ischemia continues, a marked elevation in glycerol level signals imminent 
flap loss. With double-monitoring it would be easier to create more simple follow-
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up guides with different algorithms for even inexperienced personnel to use. 
However, to make this happen, both monitoring methods would need to be 
remarkably cheaper and MD monitoring would need to be made easier for the 
personnel to use. 
6.3.2 Postoperative care 
Traditionally, patients have been postoperatively sedated in the ICU to optimize flap 
outcomes. This protocol has also been used at Tampere University Hospital. The 
sedation time has ranged between 12 and 18 h until the first postoperative morning, 
and the sedative agent used has previously been propofol with no vasopressors. 
Gradually, as a result of the present study, there has been a shift towards lighter post-
operative sedation. The patients are still followed in the ICU, but nowadays the 
primary sedative is DEX and the patients are arousable in a few hours 
postoperatively. The light sedation lasts on average for 12 to 16 h enabling earlier 
removal to a normal ward. If a vasopressor is needed, norepinephrine and dopamine 
are allowed. 
Perhaps in future, postoperative patients will be treated in a specialized head and 
neck ward without sedation. This would enable patients to recover faster and shorten 
the length of postoperative ICU and even hospital stay. Flaps will be followed by a 
reliable monitoring method and specially trained nurses effectively with no routine 
follow-up visits by the surgeon.  
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Abstract Aim of this study was to evaluate the reliability of
a continuous real-time tissue oxygen monitoring method
(Licox®) for postoperative follow-up of free microvascular
flaps after ablative head and neck tumour surgery. We also
wanted to establish and test accurate alarm levels for this
monitoring method. One hundred eighteen head and neck
cancer patients, operated in Tampere University Hospital,
Finland, were analysed. Tissue oxygen (PtiO2) levels were
continuously monitored with the Licox® system. Receiver
operating characteristic analysis was performed considering
following alarming signals: a clear change in the trend of the
curve leading to a decline more than 50% in 1 h or a decline
below 10 mmHg in the PtiO2 level. Licox® recognized all
the patients who needed re-operation with sensitivity of
100% and specificity of 88%. The overall success rate was
99.2% (117 of 118) and flap salvage rate 88% (seven of
eight), respectively. The Licox® tissue oxygen pressure
monitoring system is a reliable method for detecting early
postoperative circulation problems in free microvascular
flaps. The suggested alarm signals are a clear change in
the trend of the curve leading a decline more than 50% in
an hour or a decline below 10 mmHg.
Keywords Tissue oxygen monitoring . Free flaps .
Postoperative monitoring . Head and neck cancer
Introduction
Free microvascular flap reconstruction is a standard part of
modern head and neck tumour surgery. Although the suc-
cess rate of these reconstructions is high in experienced
hands [2, 4], postoperative circulatory impairment of the
flap is still a potential complication and leads to failure of
the whole reconstruction. A major re-operation is required
with an increased risk of complications and high cost. If a
circulatory problem can be detected early, salvage proce-
dures can be started without delay. In most cases, the recon-
struction can be saved with a simple revision of the
anastomoses.
The importance of careful postoperative monitoring has
been emphasised in many reports [1, 3]. Clinical observa-
tion and handheld Doppler ultrasound are the most common
methods while more sophisticated techniques—for example,
microdialysis—are seldom used.
In head and neck reconstructions, vitality of the flap is
often difficult to observe especially in reconstructions of
the posterior oral cavity or hypopharynx. Clinical obser-
vation and Doppler ultrasound both require experienced
personnel and multiple regular inspections of the flap
during the first 72 postoperative hours. Several methods
for monitoring circulation in these flaps have been intro-
duced, but no golden standard exists. The ideal system
should be easy to use, reliable and harmless to the flap,
and it should promptly alarm in case of circulatory
problems.
In Tampere University Hospital, a continuous, real-
time Licox® (GMS, Kiel-Mielkendorf, Germany) tissue
oxygen monitoring device has been used for postopera-
tive free flap monitoring in head and neck reconstruc-
tions since 1999. We report our experience with this
system.
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Materials and methods
Patients
The material comprised 118 head and neck tumour patients
operated at the department of Otolaryngology, Head and Neck
Surgery, Tampere University Hospital, Finland (Table 1). All
patients underwent radical removal of the tumour, a selective
neck dissection followed by a free flap reconstruction. The
donor tissue sites for reconstruction are shown in Table 2.
Tissue oxygen monitoring
Principle of the Licox® O2 probe is based on measuring
partial oxygen pressure in tissue (PtiO2). Oxygen dissolved
in the interstitial fluid corresponds to the availability of
oxygen at the cellular level. When the monitoring probe is
inserted in the flap, tissue oxygen diffuses through the
polyethylene wall of the probe to a negatively polarized
precious metal in the inner electrolyte chamber resulting
the O2 molecules to polarize into OH
− ions. This current
from the O2 reduction is the raw signal of the sensor. The 2-
cm sensitive area lies at the tip of the probe. Reliable read-
ings are obtained when all the sensors are inside the flap.
The reactions in the probe are reversible making the meas-
urements stable and continuous.
Tumour resections and reconstructions were done with
standard techniques. During the operation, the monitoring
O2 probe was inserted through skin and into the septocuta-
neous part of the flap (n0104) or into muscular tissue (n014).
Postoperatively, PtiO2 level in the flaps was continuously
observed for 72 h, first in the intensive care unit and later in
the normal ward. The PtiO2 curve was analysed continuously.
The flaps were additionally monitored by a physician with
traditional methods (i.e. colour, turgor, vital reaction and a
needle puncture if needed) once during the first postoperative
evening and later during regular office hours. Nurses caring
for the patients were instructed to alarm the surgeon if there
was a clear change in the trend of the curve leading to a
decline more than 50% in 1 h or if the PtiO2 level dropped
altogether below 10 mmHg. When one or more of these
criteria was met, the operating surgeon was called to evaluate
the flap’s condition. Decision to re-operate was based on the
PtiO2 curve and clinical signs of the flap.
Statistics
Receiver operating characteristic (ROC) analysis was per-
formed to confirm the reliability of the above mentioned
PtiO2 limits. Negative and positive predictive values were
calculated together with sensitivity and specificity.
Table 1 One hundred eighteen patients with head and neck tumours
Sex male/female 70 (59%)/ 48 (41%)
Age Mean 56 years (17–88)
Oral cancer 84 (71%)
Tonsillar cancer 24 (20%)
Hypopharyngeal cancer 5 (4%)
Sinonasal cancer 2 (2%)
Epithelioid sarcoma 1 (1%)
Mucoepidermoid sarcoma 1 (1%)
Ameloblastoma 1 (1%)
Table 2 Flaps used for
reconstruction Radial forearm 92 (78%)
Fibula 11 (9%)
Crista iliaca 5 (4%)
Rectus abdominis 4 (3%)
Scapula 3 (2,5%)
Latissimus dorsi 2 (2%)
RFA + fibula 1 (1%)
Table 3 The ROC analysis for alarming signals, which were PtiO2
level less than 10 mmHg, a clear change in the trend of the curve
leading to a decline more than 50% in 1 h
Re-operation Sensitivity 100%
Alarm Yes No Specificity 88%
Yes TP08 FP013 Positive predictive
value
0.38
No FN00 TN097 Negative predictive
value
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Fig. 1 PtiO2 curve during the vascular anastomosis phase. 1 Opening of
the arterial anastomosis. 2 Arterial clamp during venous anastomosis. 3
Arterial and venous clamp off
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Results
This monitoring method detected all cases with circulatory
problems. ROC analysis showed high negative predictive
values and good efficiency for the alarming criteria to pre-
dict the need for a re-operation. There were no false negative
cases in the whole material. The overall success rate with the
reconstructions was 99.2% (117 of 118), and salvage rate for
re-operated cases was 88% (seven of eight) (Table 3).
Typical PtiO2 curve shows a rapid response to opening
and closing of the artery during the vascular anastomosis
phase of the operation (Fig. 1). An average normal PtiO2
curve reaches a steady state within 2 h postoperatively
followed by a slow descend. At the starting point, the mean
readings were slightly higher in septocutaneous flaps than in
muscular flaps—75 vs. 52 mmHg, respectively. After 24 h,
the same readings were 60 and 40 mmHg and at 72 h 36 and
30 mmHg, respectively (Fig. 2).
In 21 patients (18%), there was a clear change in trend of
the curve, a decline of 50% in less than an hour or a decline
below 10 mmHg in the PtiO2 readings (Table 3). After
subsequent analysis of the flap’s clinical signs, a decision
to re-operate was done in eight cases. Thus, 13 of 21 (62%)
of the alarms were false positive. Six patients were operated
during the first 24 h and two later during the first 72 h. Two
patients had to be re-operated twice. One flap did not sur-
vive and had to be replaced with a new one. In seven
patients, a venous blockage occurred due to a compressing
haematoma, and there was one arterial thrombosis. A typical
curve leading to a re-operation caused by venous blockage
is shown in Fig. 3.
Discussion
Our material with 118 patients shows that this monitoring
method based on continuous PtiO2 measurement is reliable
and useful in the clinical follow-up of free flap reconstruc-
tions. To our knowledge, this is the largest published mate-
rial of head and neck patients monitored with this system. It
is remarkable that in the whole series, there were no false
negative cases and the system detected all cases with
Fig. 2 Mean PtiO2 level in
septocutaneous (grey) and
muscular (black) free flaps
Fig. 3 A typical PtiO2 curve
leading to re-operation,
showing a typical slow decline
followed by a clear change of
trend (arrow) leading to
readings below 10 mmHg after
beginning of the venous
thrombosis due to a haematoma
in the surgical field
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circulatory problems. The alarm criteria—a clear change in
the trend of the PtiO2 level leading to a decline more than
50% in an hour or PtiO2 level declining below 10 mmHg—
proved to be useful in clinical practise. These limits were
originally suggested by Hofer et al. [5]. There seem to be
two reasons for the relatively high number of false positive
alarms in this material, namely normal physiological events
occurring in the flaps’ circulation during the immediate
postoperative period and high sensitivity of the PtiO2 probe.
The variability of postoperative PtiO2 levels may cause
some confusion. High readings immediately after surgery
are due to ischaemia and local microtrauma, which damages
mitochondria of the cells and results in high extracellular O2
concentrations. During the first two postoperative hours,
PtiO2 stabilizes and reaches a steady level. Since the system
reacts rapidly to changes in PtiO2 levels, possible ischaemia
is naturally detectable also during this stabilization period.
In the following 72 h, the readings start to decline slowly
even without any circulatory problems. This decline is due
to tissue autoregulation, which is thought to be caused by
both circulating metabolites and vasoconstriction of the flap
arterioles [7]. Also, the fact that in subcutaneous flaps the
initial PtiO2 readings are higher and the decline of the curve
steeper than in muscular flaps might cause some uncertainty.
This, however, can be explained by the differences in dis-
tribution of microcirculation and oxygen uptake in subcuta-
neous and muscular tissue. The PtiO2 reaches an equal level
in both flaps within 72 h (Fig. 1). Although the readings
vary somewhat individually, the trend seems to be the same
in all cases. These findings are in accordance with those of
Kamolz et al. [6].
We have noticed that external manipulation of the probe
triggers immediate changes in the subsequent PtiO2 read-
ings. Suctioning, restlessness of the patient or manipulation
of the reconstruction can cause a sharp temporary rise or
decline in the curve. To eliminate this, we find it beneficial
to keep the patient under sedation for the first 12–18 post-
operative hours and try to minimize mechanical manipula-
tion of the reconstructed area. It is also important to fix the
probe so that it does not move out of place when the
reconstruction is observed or suction is applied.
In the early part of this series, variation in the PtiO2
curves, caused by the previously discussed reasons, quite
understandably resulted in several alarms. Clinical experi-
ence and comprehension of the flaps physiology and circu-
lation greatly diminishes the false positive interpretations of
the PtiO2 readings.
Since the specificity of the system is 88%, one has to
acknowledge that this system is not an absolute monitoring
system but an alarm system still requiring clinical observation
and decision making. However, we would like to point out
that all false alarms were false positive and thus makes this
system highly sensitive to any actual circulatory problems.
As we stated earlier, a monitoring system should be easy
to use, reliable and harmless to the flap, and it should
promptly alarm in case of circulatory problems. This system
seems to accomplish those requirements. A most remarkable
practical advantage is the possibility to basically abandon
continuous clinical follow-up of the flap during the imme-
diate postoperative period. Instead of having the surgeon
checking clinical signs regularly during the first 72 postop-
erative hours, nurses can easily monitor continuous real-
time data of the flaps circulation and alarm the surgeon only
if needed.
Conclusion
The Licox® tissue oxygen monitoring system is a sensitive
and reliable tool for monitoring microvascular reconstruc-
tions in the head and neck area. It enables continuous real-
time observation of circulation in microvascular free flaps.
This can easily be done by the nursing staff thus remarkably
reducing clinicians work. With the suggested alarm criteria,
100% of the vascular events threatening the flap could be
noticed, and measures to prevent flap loss started without
delay.
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 Abstract 
 Background. Extracellular glycerol as detected by microdialysis has been used as a surrogate marker for (ischemic) tissue 
damage and cellular membrane breakdown in the monitoring of free microvascular musculocutaneous ﬂ aps. One confound-
ing factor for glycerol as a marker of ischemic cell damage is the effect of lipolysis and associated glycerol release as induced 
by sympathetic signalling alone. We hypothesized that extracellular glycerol concentrations in a microvascular ﬂ ap with 
sympathetic innervation would be confounded by intact innervation per se as compared to denervated ﬂ ap. Clinical relevance 
is related to the use of both free and pedicled ﬂ aps in reconstructive surgery. We tested the hypothesis in an experimental 
model of microvascular musculocutaneal ﬂ aps.  Methods. Twelve pigs were anesthetized and mechanically ventilated. Two 
identical rectus abdominis musculocutaneal ﬂ aps were raised for the investigation. In the A-ﬂ aps the adventitia of the artery 
and accompanying innervation was carefully stripped, while in the B-ﬂ aps it was left untouched. Flap ischemia was induced 
by clamping both vessels for 60 minutes. The ischemia was conﬁ rmed by measuring tissue oxygen pressure, while extracel-
lular lactate to pyruvate ratio indicated the accompanying anaerobic metabolism locally.  Results. Intramuscular and sub-
cutaneal extracellular glycerol concentrations were measured by microdialysate analyzer. Contrary to our hypothesis, glycerol 
concentrations were comparable between the two ischemia groups at 60 minutes ( p    0.089, T-test).  Conclusions. In this 
experimental model of vascular ﬂ ap ischemia, intact innervation of the ﬂ ap did not confound ischemia detection by glycerol. 
Extrapolation of the results to clinical setting warrants further studies. 
 Key Words:  Glycerol ,  microdialysis ,  postoperative monitoring ,  free ﬂ aps ,  pedicled ﬂ aps ,  ﬂ ap ischemia 
 Introduction 
 Free microvascular ﬂ aps and pedicled ﬂ aps with 
intact innervation are routinely used for reconstruc-
tion of large tissue defects during tumor surgery. 
Postoperative circulatory impairment of the ﬂ ap leads 
to failure of the reconstruction and often a major re-
operation is required with an increased risk of com-
plications. Even though the frequency of postoperative 
circulatory failures may be low, the consequences for 
the individual patient are devastating with costly re-
operations and prolonged hospitalization. If the tissue 
perfusion defect is detected early enough, attempts 
to salvage the ﬂ ap can be started immediately and in 
most cases the reconstruction can be restored with a 
revision of the anastomoses [1 – 3]. 
 The clinical estimation of the vitality of the tissue 
may be difﬁ cult especially in buried ﬂ aps in the pos-
terior oral cavity or hypopharynx. Clinical observa-
tion requires repeated inspections of the ﬂ ap by 
experienced personnel during the ﬁ rst 72 postopera-
tive hours with obvious inter-individual variation. 
There have been attempts to ﬁ nd more objective 
methods for monitoring tissue perfusion but no 
golden standard is yet available [2 – 4]. 
 Tissue partial pressure of oxygen (P Ti O 2 ) mea-
sured continuously and directly from the tissue 
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reﬂ ects best the circulatory status, and more pre-
cisely, balance between oxygen supply and extraction 
in the tissue [2,5]. 
 Microdialysis (MD) is used for cerebral monitor-
ing in intensive care units and also in free ﬂ aps both 
in research and in clinical setting [6 – 8]. It enables 
sampling of extracellular ﬂ uid for measurement con-
centrations of intermediary metabolites such as glu-
cose, lactate, and pyruvate. In addition, microdialysate 
glycerol has been used as a marker of disintegrating 
cell membranes. However, lipolysis only, as induced 
by sympathetic stimulus may increase extracellular 
concentration of glycerol. Thereby, variation in sym-
pathetic drive is potentially a confounding factor for 
glycerol as a marker of ischemic cell membrane dis-
integration. Surgical procedures cause lipolysis either 
due to ischemia or sympathetic stress [9 – 11]. Finally, 
lactate alone [12] and the lactate to pyruvate ratio 
could be related to enzyme activity changes without 
tissue hypoxia. Therefore, combining more than one 
parallel measure of tissue perfusion and metabolism 
(multimodal monitoring) may offer more reliable 
results for study purposes and for decision making 
in the clinical setting. 
 While decreasing P Ti O 2 and glucose concentra-
tion or increasing the lactate/pyruvate-ratio (L/P-
ratio) have been considered somewhat straightforward 
measures of inadequate substrate supply and altered 
metabolism [14], extracellular glycerol could depict 
the cellular damage. The remaining drawback is that 
glycerol can be confounded by the degree of sympa-
thetic inﬂ ow to the local vasculature. The role of 
adrenergic regulation of lipolysis mediated via  β -
adrenoceptors is unclear in free ﬂ aps. Previously 
glycerol has been measured both in free ﬂ aps and in 
pedicled ﬂ aps, but the effect of sympathetic denerva-
tion was not compared [15]. 
 In this paper we report the effect of sympathetic 
denervation on the extracellular glycerol concentra-
tions during experimental ﬂ ap ischemia as compared 
to the ﬂ aps with intact innervation. 
 Material and methods 
 The results for the present publication come from a 
larger trial from which some of the results were pub-
lished recently [16]. The present report does not 
repeat the data presented earlier. While the previous 
report described a comparison of the sedation meth-
ods, the present report focuses on the time period in 
the experiment which was not reported therein. In 
general terms, in order to minimize the risk for 
experimental animals and promote efﬁ cient use of 
research funds and experimental animals it is ethi-
cally justiﬁ ed to report all different aspects from a 
single experimental study while speciﬁ cally clarifying 
that no attempt to unjustiﬁ ed splicing or repetition 
of data occurs. 
 Animals and anesthesia 
 After the approval from the institutional committee 
of care and use of experimental animals, 12 domestic 
pigs (25 – 40 kg) were deprived of food but not water 
24 h prior to experiments. Premedication with atro-
pine 0.05 mg/kg of body weight, azaperone 8 mg/kg 
and ketamine 5 – 10 mg/kg intramuscularly were fol-
lowed by cannulation of an ear vein and intravenous 
administration of 2 mg/kg propofol before tracheot-
omy. Anesthesia was maintained with propofol 
(15 – 20 mg/kg/h) and fentanyl (30  μ g/kg/h until the 
end of surgery, 5  μ g/kg/hour thereafter). Vecuronium 
bolus injections of 4 mg were given when necessary. 
The animals were ventilated with a volume-controlled 
mode (Servo 900, Siemens, Elema AB, Solna 
Sweden) with 5 cmH 2 O of positive end-expiratory 
pressure (PEEP). FIO 2 (0.3 – 0.6) was adjusted to 
keep PaO 2 levels between 13.3 kPa (100 mmHg) and 
20 kPa (150 mmHg). Tidal volume (V T ) was kept at 
10 mL/kg and the minute ventilation adjusted to 
maintain PaCO 2 levels between 4.5 and 5.5 kPa 
(34 – 41 mmHg). 
 Animal preparation 
 A ﬂ uid ﬁ lled catheter was inserted into the left fem-
oral artery (single-lumen central venous catheter, 
Arrow) and a pulmonary artery catheter (7.5F ﬂ ow-
directed, Arrow, Arrow International Inc, Reading, 
PA) introduced via the right internal jugular vein. 
Kefuroxim 750 mg IV was administered before 
instrumentation as antibiotic prophylaxis. During 
instrumentation the animals received 5 mL/kg/h 
infusions of saline, Ringer ’ s acetate and hydroxyethyl 
starch. Additional ﬂ uid was administered if necessary 
to keep pulmonary artery occlusion pressure (PAOP) 
between 5 and 8 mmHg. Body temperature of the 
animals was kept above 38 ° C using an operating 
table heater and warmed ﬂ uids when necessary. After 
the experiment, the animals were put down with a 
lethal dose of intravenous magnesium sulphate. 
 Experimental protocol 
 Two symmetrical rectus abdominis myocutaneous 
ﬂ aps (7   10 cm) were raised on each side of the 
upper abdomen with blood supply by superior epi-
gastric vessels. The adventitia with its sympathetic 
nerve ﬁ bers was carefully stripped from the arteries 
in one ﬂ ap (A-ﬂ ap), while innervation was left 
untouched in the B-ﬂ ap. Flaps were ﬁ xed in their 
original positions with skin sutures. Sixty minutes of 
hemodynamic stabilization was allowed after surgical 
preparation. Finally, 60 min global ﬂ ap ischemia was 
induced by occluding the pedicular vessels with Ack-
land V2 or V3 clamps. Ischemia was followed by 90 
min of reperfusion (Figure 1). The data describing 
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the immediate reperfusion period following the isch-
emic time for 60 min is reported herein. These data 
were not reported in the previously published report 
focusing on comparison between two sedative proto-
cols. In addition, we explicitly state that the sedation 
protocol was identical until the 60 min reperfusion. 
 Monitoring 
 Femoral arterial pressure, pulmonary arterial pres-
sure (PAP) and central venous pressure (CVP), were 
recorded with quartz pressure transducers and dis-
played continuously on a multimodular monitor (S/5 
Compact Critical Care Monitor, Datex-Ohmeda @ , 
Helsinki, Finland). Data were collected and after-
wards ﬁ ltered into 2-min medians and stored through 
a dedicated information management system (Clini-
soft, Datex-Ohmeda @ , Helsinki, Finland). All pres-
sure transducers were calibrated simultaneously to 
the level of the heart. Cardiac output (L/min) was 
measured by a thermodilution technique (mean 
value of three measurements, cardiac output module, 
Datex-Ohmeda @ , Helsinki, Finland). Heart rate was 
measured from the ECG, which was also continu-
ously monitored. 
 Microdialysis 
 A microdialysis catheter (CMA 20 Microdialysis 
Catheter, CMA/Microdialysis AB, Stockholm, 
Sweden) was used with precision perfusion pump 
(CMA 100 Microinjection Pump, CMA/Microdi-
alysis AB, Stockholm, Sweden). The methodology 
has been described elsewhere [17 – 19]. Two cathe-
ters were inserted just under the dermal layer of 
the skin (one in each rectus abdominis myocutane-
ous ﬂ ap) and another two catheters were inserted 
into the muscle (one in each ﬂ ap). The dialysate 
samples with 1  μ l/min ﬂ ow rate and 30-min time 
interval were collected. The dialysate samples were 
analyzed for glucose, lactate and pyruvate and glyc-
erol concentrations at the end of stabilization and 
at 30 and 60 min after global ﬂ ap ischemia by a 
microdialysis analyzer (CMA 600 Microdialysis 
Analyzer, CMA/Microdialysis AB). 
 Tissue-oxygen partial pressure 
 We used a P Ti O 2 probe that is routinely used in clin-
ical setting for the monitoring of brain tissue oxygen-
ation and in free-ﬂ ap surgery [2,13]. Standard CC1.2 
microcatheter tissue-oxygen partial pressure (P ti O 2 ) 
probes (Licox, Integra, Hampshire, UK) were used 
for the measurements. Two P Ti O 2 probes were used 
intramuscularly, one in each rectus abdominis myo-
cutaneous ﬂ ap. No catheters were inserted under the 
dermis. Tissue-oxygen pressure was intermittently 
monitored from each probe in periods of 5 min from 
the end of the stabilization period until the end of 
the experiment (Licox, GMS, Kiel-Mielkendorf, 
Germany). Repeated P ti O 2 values were graphically 
displayed on a linked laptop and data was automati-
cally registered every 20 seconds. 
 Data analysis and statistics 
 Power calculation for sample size was not performed. 
Instead a convenience sample size was chosen. The 
normality of the data was tested with the Kolmogo-
rov-Smirnov test (K-S test). Thereafter the data are 
presented as mean   standard deviation (SD) unless 
otherwise mentioned. The T-test was used for all sta-
tistical analyses (intramuscular and subcutaneous 
glycerol in A-, B-ﬂ aps and control). Bonferroni cor-
rection was used due to multiple testing. A value of 
 p    0.05 was considered signiﬁ cant. 
 Results 
 The data were normally distributed according to the 
K-S test. Systemic hemodynamics and arterial oxy-
genation were stable at the end of the stabilization 
and after 60 min of the local ﬂ ap ischemia (Table I). 
Decreasing muscle tissue O 2 tension (P Ti O 2 ) con-
ﬁ rmed ﬂ ap ischemia and increasing L/P ratio sug-
gested anaerobic metabolism at 30 and 60 min 
during the occlusion of vessels (Table II). At 30 min 
after occlusion of arterial supply and venous return 
to the ﬂ ap, the L/P ratio was higher in denervated 
ﬂ aps ’ muscle tissue in comparison to the ﬂ aps with 
intact innervation (Table II,  p    0.014). 
 Before and during ischemia (baseline, 30 and 60 
min) extracellular glycerol concentrations were com-
parable in denervated ﬂ aps and in ﬂ aps with intact 
innervation. After 60 min of ischemia no signiﬁ cant 
differences between the two groups were detected 
 Figure 1. The study setting: Instrumentation was followed by 
stabilization, ischemia and reperfusion. The microdialysis 
measurement time points are shown as black dots, while P ti O 2 
was followed continuously. 
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( p    1.0 and  p    0.18, subcutaneal and intramuscular 
samples, respectively, Figure 2). A marked increase 
over time only occurred after 60 min in both dener-
vated ﬂ aps ’ subcutaneal and intramuscular microdi-
alysate ( p    0.0002 and  p    0.016, respectively) and 
in the ﬂ ap with intact innervation; subcutaneal 
and intramuscular microdialysate ( p    0.0002 and 
 p    0.0002, respectively). Subcutaneal or intramuscu-
lar microdialysate glycerol concentration at 60 min 
of ischemia were not different between the groups 
( p    0.94 and  p    0.84). A comparable behaviour of 
intramuscular P ti O 2 in relation to extracellular glyc-
erol concentration over time is depicted in Figure 3. 
 After 60 min of reperfusion, intramuscular 
microdialysate glycerol concentration was compara-
ble in the two groups, 62    31 micromol/L and 
48    27 micromol/L in the denervated ﬂ ap and in the 
ﬂ ap with intact innervation, respectively ( p    0.5). 
 Discussion 
 The main ﬁ nding of the present experiment was that 
opposite to our original hypothesis, intact innerva-
tion of the microvascular ﬂ ap did not contribute to 
intramuscular extracellular glycerol release as com-
pared to the denervated ﬂ ap after 60 min of ischemia. 
Surprisingly, we found that the L/P ratio increased 
to a higher extent earlier on in the denervated ﬂ ap. 
 Sympathetic stress and ischemia during opera-
tion are known to increase lipolysis [10,22,23]. This 
can be detected as elevated extracellular glycerol 
concentrations by microdialysis. Accepting the notion 
that sympathetic activity alone is one of the stimuli 
for glycerol release, we hypothesized that the con-
founding effect of lipolysis due to intact sympathetic 
drive rather than ischemia could be measured as 
higher or variable levels of glycerol in microvascular 
ﬂ aps with intact innervation [24]. Contrary to the 
hypothesis our experiment showed no signiﬁ cant dif-
ference between denervated and the ﬂ aps with intact 
innervation. Glycerol concentrations increased only 
moderately (as compared to baseline) even after 
60 min of no blood ﬂ ow while the lactate to pyruvate 
ratio was already several-fold (5 – 10 times SD of the 
baseline setting) higher after 30 min as compared to 
the baseline measures. 
 From the clinical perspective, postoperative mon-
itoring of the viability of free microvascular ﬂ aps is 
important. In particular, head and neck cancer sur-
gery portends high risks for adverse events; ﬂ aps are 
usually buried or otherwise difﬁ cult to observe. 
Several monitoring methods have been introduced 
to clinical use such as P ti O 2 and microdialysis 
[5,8,11,13,14]. P ti O 2 measurement provides the 
clinician with on-line information of tissue oxygen 
levels. The method however supplies the clinician 
with variable baseline absolute P ti O 2 level. Thereby 
adding metabolic monitoring along P ti O 2 measure-
ments could offer additional information for clinical 
decision-making. While the L/P ratio is considered as 
a clear indicator of anaerobic metabolism locally, 
glycerol release from cells is a less robust indicator 
of ischemia. The present study indicates that glycerol 
is minimally confounded by the sympathetic innerva-
tion or lack of it. Thereby it may add to the diagnos-
tics of the tissue perfusion defect indicated by low 
P ti O 2 and high L/P ratio equally in free microvascu-
lar ﬂ aps and pedicled ﬂ aps with intact innervation. 
Thus a stepwise diagnostic approach is possible: 
P ti O 2 indicates the early perfusion (O 2 supply) fail-
ure, increasing L/P ratio conﬁ rms metabolic derange-
ment and ﬁ nally, increasing glycerol concentration 
indicates already the start of cell injury related to 
ischemic conditions. In the present experiment we 
obtained results which, contrary to our hypothesis, 
suggest that glycerol release was not modiﬁ ed by the 
sympathetic innervation either in muscle tissue or in 
 Table II. The mean/SD values for the muscle preparates showing clearly the signs of 
ischemia and reperfusion in the study groups.  
Baseline 
 ( n    12)
 30-min ischemia
 ( n    12)
 60-min ischemia
 ( n    12) 
 Muscle PtiO 2 (mmHg) 
 Denervated 20    10  2    5  †  0.5    1  †  
 Innervated 24    13  3    4  †  1    2  †  
 Muscle MD- Lactate/Pyruvate 
 Denervated 24    10  111    63  * , †  238    119  †  
 Innervated 19    10  52    27  †  183    95  †  
  ∗  Denotes the difference between the groups (T-test,  p    0.05).   †  Denotes the difference 
to the baseline (Paired T-test    0.05). Bonferroni correction for repeated measure-
ments was used. 
 Table I. The hemodynamic parameters remained stable throughout 
the experiment. 
Baseline 
 ( n    12)
30-min 
ischemia 
( n    12)
60-min ischemia
 ( n    12)
MAP (mmHg) 77    11 77    10 77    7
CO (L/min) 4    1 4    1 4    1
Arterial PO 2 (kPa) 23    4 22    4 22    4
Arterial L/P ratio 11    2 11    3 11    3
 MAP, mean arterial pressure; CO, cardiac output. 
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subcutis. Previously, Navegantes and colleagues 
showed in a human model of sympathetic excitation 
that glycerol release was not increased in skeletal 
muscle by sympathetic activation alone. Conversely, 
in adipose tissue sympathetic activation alone 
increased glycerol release [25]. Finally, the early, pro-
nounced increase of the L/P ratio 30-min time point 
during ischemia in denervated ﬂ ap is in contrast 
to the report by Qvist and colleagues. They showed 
that sympathetic activation in human skeletal muscle 
increases lactate concentration in the intramuscular 
extracellular compartment [26]. We cannot explain 
the differences between the present report and previ-
ous studies. The role of the potential confounding 
effect of sedation in an animal model as opposed to 
the awake state in human volunteer trials can be 
speculated. 
 There are limitations to our study. One weakness 
of the methods is the lack of objective measures of 
sympathetic activity locally. However, we aimed to 
simulate closely the clinical setting for perioperative 
conditions. Even though we used the most precise 
atraumatic surgical technique in preparation of the 
ﬂ aps and the most delicate surgical clamps, we can-
not deﬁ nitely exclude the possibility that clamping of 
the vessels (and the surgical manipulation) may have 
 Figure 3. The effects of ischemia on muscle tissue pO 2 (P Ti O 2 ) and 
muscle microdialysate glycerol concentration (MD-glycerol) is 
depicted as an x-y plot with mean (squares and circles)   standard 
deviations (error bars) at the baseline (right-most), 30 min of 
ischemia (second to left) and after 60 min of ischemia (left-most) 
in denervated ﬂ aps (  ) and the ﬂ aps with intact innervation (  ). 
 
Figure 2. No statistical difference was observed between innervated and denervated glycerol-levels at baseline or during ischemia at 
30 min or 60 min in subcutaneal (intradermal) or intramuscular microdialysate. Data is shown as median, quartiles and 95% conﬁ dence 
intervals. The asterisk denotes  p    0.05, within the group comparison from baseline to 60-min, paired T-test,  n    12 at each timepoint in 
each group. 
  Glycerol as an indicator of tissue ischemia  425
affected the sympathetic innervation leading to an 
abnormal innervation on ﬂ ap-B. Importantly, the 
adventitia of the supplying artery was carefully 
stripped off from one of the ﬂ aps, while the other was 
left intact. Secondly, the experiment was performed 
on anesthetized pigs. This may limit the physiological 
relevance of the results. Deep sedation may have 
effects on the metabolism and therefore on, for 
example, glycerol release. However, here we suggest 
that the conditions mimic the clinical setting includ-
ing the use of propofol as the anaesthetic. In addi-
tion, the sedation was identical between the groups. 
Finally, as this was a convenience sample size instead 
of power calculated to detect a certain difference 
between the groups we cannot fully rule out the pos-
sibility of erroneous negative ﬁ ndings. 
 In summary, decreasing P ti O 2 and increasing the 
L/P-ratio indicated ischemia and anaerobic metabo-
lism in both the denervated ﬂ ap and the ﬂ ap with intact 
innervation. Surprisingly, denervation was associated 
with a more pronounced increase in intramuscular L/P 
ratio at 30 min of vascular occlusion. Contrary to our 
hypothesis glycerol release was not altered by the 
presence or absence of ﬂ ap innervation. 
 Bearing in mind the limitation of a small sample 
size we suggest in conclusion that glycerol release 
from cells into the extracellular space is not con-
founded by the sympathetic innervation during deep 
sedation. 
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Microvascular ﬂaps are used for head and neck area reconstruction after extensive tumor surgery. Comorbidities and the duration of surgery, anaesthesia, and sedation may lead to decreases in the mean arterial pressure intraoperatively and postoperatively, requiring 
the use of vasopressors.1 Treatment with vaso-
pressors is controversial, however, because of the 
possibility of a vasoconstriction-induced decrease 
in ﬂap perfusion, leading to ﬂap ischemia and 
thrombosis. Therefore, up to 52 percent of sur-
veyed anesthesiologists prefer to manage blood 
pressure decreases with crystalloid infusion; only 
36 percent of them considered vasopressors to 
be safe, and 46 percent of them regarded the use 
of norepinephrine to be contraindicated.2 The 
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Background: Patients undergoing ablative and reconstructive head and neck 
surgery with a microvascular ﬂap have multiple factors that potentially decrease 
postoperative mean arterial pressure, which may endanger ﬂap survival. The 
safety of vasopressor use has long been a topic of discussion. The authors ana-
lyzed the effect of vasopressors on microvascular ﬂap perfusion after head and 
neck cancer reconstruction.
Methods: A total of 27 patients were enrolled in a randomized, controlled, 
clinical trial. A microvascular radial forearm ﬂap was used for reconstruction. 
Patients were allocated into one of three groups: dopamine, norepinephrine, 
and control. The intervention groups received the vasoactive drug, aiming to 
maintain the mean arterial pressure between 80 and 90 mmHg. Normovole-
mia was maintained according to central venous pressure. Flap perfusion was 
monitored with continuous tissue partial pressure of oxygen and microdialy-
sate metabolite (lactate-to-pyruvate ratio) measurements.
Results: No adverse effects were observed, and postoperative recovery was free 
of complications in all groups. Neither the lactate-to-pyruvate ratio nor con-
tinuous tissue partial pressure of oxygen values differed signiﬁcantly between 
groups during the ﬁrst 24 hours of the vasoactive drug infusion period or 
during the 72-hour follow-up.
Conclusions: Norepinephrine and dopamine are safe and effective vasopres-
sors for use during the postoperative period following head and neck cancer 
surgery with microvascular reconstruction. Dopamine should be used with cau-
tion, however, because of the risk of side effects. (Plast. Reconstr. Surg. 137: 
1016e, 2016.)
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use of massive ﬂuid infusions may have negative 
pulmonary and circulatory effects, and prolong 
the hospital stay.2,3 Preferred drugs for manag-
ing mean arterial pressure are sympathomimetic 
amines, or mixed alpha-/beta-adrenergic drugs 
titrated to the patient’s needs.
Recent reports indicate that the use of vaso-
pressors does not pose a negative threat to ﬂap 
vitality.1,3–5 In a study by Eley et al., norepinephrine 
caused vasoconstriction in the ﬂap but to a lesser 
extent than in the control tissue.1 Therefore, 
ﬂap skin blood ﬂow increased with an increase 
in arterial blood pressure. Dobutamine modestly 
increased the ﬂap blood ﬂow. In a study by Scholz 
et al., dobutamine was used for head and neck 
microvascular ﬂap patients, and blood ﬂow mea-
sured at the arterial anastomosis site indicated 
that dobutamine improved free-ﬂap perfusion.3
Different protocols are followed during the 
ﬁrst 24 hours postoperatively to ensure optimal 
patient care.2,3 Because the operation is extensive, 
patients may have moderate blood loss, requiring 
a period of ﬂuid and airway monitoring, reposi-
tioning, and adjustment, and it is considered that 
these patients are better cared for in an intermedi-
ate or intensive care unit. Furthermore, although 
there is some disagreement, it is common practice 
to maintain the patient under sedation and venti-
lation during the ﬁrst 24 hours.1,6,7 Sedation may 
cause systemic vasodilation, leading to decreased 
mean arterial pressure, and potentially compro-
mise ﬂap survival.2,3 In addition, ﬂaps undergo a 
series of inﬂammatory and circulatory adjustments 
for which careful monitoring is advised. The aim 
of this randomized clinical study was to analyze, 
by continuous tissue partial pressure of oxygen 
monitoring and microdialysis metabolite measure-
ments, the effect of norepinephrine and dopamine 
on microvascular radial forearm ﬂaps after head 
and neck cancer ablation and reconstruction.
PATIENTS AND METHODS
The Ethics Committee of Tampere Univer-
sity Hospital and the Finnish National Agency of 
Medicine approved the study. Written informed 
consent was obtained from the patients. A total 
of 27 consecutive head and neck cancer patients 
(15 oral and 12 oropharyngeal) were included 
in our unblinded randomized controlled trial. 
Patient demographics are listed in Table 1. Blocks 
of nine patients were used for randomization, and 
the allocation was performed by the medical/
research nursing staff in the intensive care unit. 
Operations were performed using a two-team 
approach in which tumor removal, functional 
neck dissection, and microvascular reconstruc-
tions were performed by one senior ear, nose, 
and throat surgeon with standard techniques. An 
experienced plastic surgeon performed the har-
vesting of the radial forearm ﬂap. The preferred 
receptor vessels for anastomosis were the facial 
artery and the venous tributaries in proximity to 
the internal jugular vein in all study patients.
Flap perfusion and vitality were monitored con-
tinuously using a continuous tissue partial pressure 
of oxygen monitoring catheter (Licox; Integra, 
Hampshire, United Kingdom) and a microdialysis 
catheter (CMA 20 Microdialysis Catheter; CMA/
Microdialysis AB, Stockholm, Sweden) inserted 
into the subcutaneous tissue of the ﬂaps before 
performing the ﬂap insertion and microvascular 
anastomosis. Clinical parameters such as ﬂap tem-
perature, color, turgor, and capillary ﬁlling were 
also followed by the nursing staff. Postoperatively, 
patients were monitored in the intensive care unit 
under sedation with propofol (infusion at a maxi-
mum dose of 4 mg/kg/hour) for 24 hours, which 
is the regular practice in our department. Nor-
movolemia was maintained with central venous 
pressure between 6 and 10 cmH
2O. Patients were 
randomized into one of three unblinded groups: 
control, dopamine, and norepinephrine. In the 
control group, no attempts to increase mean arte-
rial pressure were made provided that it remained 
greater than 60 mmHg. In both intervention 
groups, mean arterial pressure was maintained 
between 80 and 90 mmHg with either dopamine 
[Abbodop (Abbott, Cherry Hill, N.J.; Electra-Box 
Pharma, Stockholm, Sweden); maximum dose, 
13.3 µg/kg/minute] or norepinephrine [Levo-
phed (Hospira, Lake Forest, Ill.); maximum dose, 
0.33 µg/kg/minute]. Preset mean arterial pres-
sure limits were followed with an intention-to-treat 
principle. Infusion rates of the study medications 
were titrated, if needed, during the ﬁrst postopera-
tive 24 hours. Mean arterial pressure and central 
venous pressure were measured simultaneously.
Postoperative ﬂap follow-up, in addition to a 
thorough clinical evaluation, was performed by 
continuous tissue partial pressure of oxygen mon-
itoring (Licox; GMS, Kiel-Mielkendorf, Germany) 
and microdialysis metabolite measurements 
(CMA 600 Microdialysis Analyzer; CMA/Microdi-
alysis AB) for 72 hours postoperatively.
Continuous tissue partial pressure of oxygen 
readings were recorded continuously on com-
puter software, and microdialysis metabolites 
were analyzed every 2 hours for the ﬁrst 24 hours, 
and then every 3 hours for the next 48 hours. A 
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commercially available metabolite kit was used 
(Iscusﬂex; M Dialysis AB, Johanneshov, Sweden) 
for analysis of lactate, pyruvate, glucose, and glyc-
erol levels. The lactate-to-pyruvate ratio was calcu-
lated every 2 hours by the computer software. A 
remarkable increase (up to the hundreds) in the 
lactate-to-pyruvate ratio or a decrease in continu-
ous tissue partial pressure of oxygen to less than 
10 mmHg after achieving a plateau was consid-
ered to indicate compromised ﬂap circulation.
The sample size was calculated (80 percent 
power; α = 5 percent) by using PS Power and sam-
ple size calculator. The main variable was lactate-
to-pyruvate ratio, with values ranging from 30 to 40 
considered signiﬁcant. Two patients were excluded 
from the analysis because of missing microdialy-
sis or continuous tissue partial pressure of oxygen 
data. Data were analyzed by the Wilcoxon and 
Friedmann and Mann-Whitney tests using IBM 
SPSS Version 22 (IBM Corp., Armonk, N.Y.).
RESULTS
This study included 14 men and 11 women 
with a mean age of 61 ± 13 years. Table 1 shows 
the patient characteristics per study group. The 
overall treatment time in the three study groups 
was 1900 minutes (1815 to 1954 minutes).
All surgical interventions and postoperative 
recoveries in the intensive care unit and ear, nose, 
and throat ward were free of complications. Heart 
rate, central venous pressure, and mean arterial 
pressure are shown in Figure 1. Mean arterial pres-
sure measurements showed greater stability in the 
norepinephrine group. The dopamine group had 
the greatest variation in mean arterial pressure 
levels and heart rate (Fig. 2, below). In the con-
trol group, three of eight patients required small 
amounts of both vasopressor agents to maintain 
the preset mean arterial pressure levels greater 
than 60 mmHg (Table 2).
Lactate-to-pyruvate ratio and continuous tissue 
partial pressure of oxygen measurements followed 
a similar pattern in every study group (Fig. 2). The 
behavior of these values was similar in all three 
groups during continuous monitoring for 72 hours. 
There were no statistically signiﬁcant differences in 
partial tissue oxygenation and lactate-to-pyruvate 
ratio levels at any time point between the study 
groups undergoing treatment with vasoactive drugs.
There were no ﬂap losses or major complica-
tions leading to reoperations in any of the groups. 
One patient in the dopamine group developed 
signiﬁcant tachycardia that required a medication 
dose decrease.
DISCUSSION
Patients with head and neck cancer under-
going tumor ablation and microvascular 
Table 1. Patient Demographics
Dopamine Norepinephrine Control Total
No. of patients 8 9 8 25
Mean age ± SD, yr 63 ± 14 65 ± 8 55 ± 16
Sex
  Male 4 5 4 13
  Female 4 4 4 12
Chronic renal insufﬁciency 0 0 0 0
Diabetes mellitus 1 1 0 2
Hypertension 4 2 0 6
Chronic pulmonary disease 0 0 1 0
Cerebrovascular disease 0 0 1 0
Coronary artery disease 0 0 1 0
Peripheral vascular disease 0 0 0 0
Hypercholesterolemia 2 1 0 3
Previous radiation therapy 0 1 0 1
Smoking 3 4 4 11
Localization
  Oral 4 5 5 14
  Oropharyngeal 4 4 3 11
Tumor size
  T1 1 1 2
  T2 4 6 5 15
  T3 2 1 2 5
  T4 1 1 1 3
Lymph node status
  N0 5 5 5 15
  N1 0 3 1 4
  N2 3 1 2 6
Copyright © 2016 American Society of Plastic Surgeons. Unauthorized reproduction of this article is prohibited. 
Volume 137, Number 6 • Norepinephrine, Dopamine, and Perfusion
1019e
Fig. 1. (Above) Mean central venous pressure measurements and confidence intervals per unit of 
time among the study group patients after head and neck cancer ablative surgery and microvas-
cular reconstruction. (Center) Mean heart rate measurements and confidence intervals per unit of 
time among the study group patients after head and neck cancer ablative surgery and microvas-
cular reconstruction. (Below) Mean arterial pressure (MAP) measurements and confidence intervals 
per unit of time among the study group patients after head and neck cancer ablative surgery and 
microvascular reconstruction.
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reconstruction often experience systemic changes 
caused by prolonged major surgery with tissue 
trauma, ﬂuid loss, and possible hypothermia. 
These factors, combined with patient comorbidi-
ties and use of vasodilator sedatives such as propo-
fol, place patients at a great risk for hypotension. 
Control of intraoperative and postoperative 
blood pressure and avoidance of hypotension is 
a determining factor for adequate microvascular 
ﬂap perfusion.2,8 Patient postoperative manage-
ment has been a matter of debate in the reviewed 
literature. In our clinic, the protocol is patients 
undergoing a standard period of 24 hours of post-
operative sedation for adequate resuscitation, 
pressure management, and comfort.
The use of vasopressors to maintain sufﬁcient 
blood pressure in reconstructive surgery without 
adverse effects has been actively studied.9-15 The 
physiopathology of the actions of vasopressors is 
well known. Norepinephrine reacts very speciﬁ-
cally with α-receptors in the peripheral vessels as 
opposed to the β-receptors in the heart. In contrast, 
Fig. 2. (Above) Mean microdialysate flap lactate-to-pyruvate (L/P) ratio values and confidence 
intervals per unit of time in study groups of patients undergoing head and neck cancer ablation 
and microvascular flap reconstruction. (Below) Mean partial tissue oxygen readings and confi-
dence intervals per unit of time in study groups of patients undergoing head and neck cancer 
ablation and microvascular flap reconstruction.
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dopamine has both adrenergic and dopaminer-
gic actions. Whereas the effects of dopamine are 
more dose-dependent, smaller doses almost exclu-
sively affect the β-receptors of the heart, which 
raises the heart rate, whereas larger doses mainly 
affect the peripheral vasculature. Dopamine has 
properties distinct from dobutamine in that it is 
a naturally occurring catecholamine with fewer 
inotropic and arrhythmogenic effects and greater 
effects on blood pressure.
The use of vasopressors is considered a dan-
ger to ﬂap survival and thus crystalloid infusion is 
generally preferred to maintain the mean arterial 
pressure level.2 Early experimental animal models 
with free ﬂaps showed that the use of vasopressors 
could potentially lead to vasoconstriction in the 
ﬂap microcirculation.16,17 This is based on the fact 
that denervated tissue seems to preserve some of 
its previous adrenergic control with higher vaso-
constrictor reactivity to α-adrenergic drugs such 
as norepinephrine.9,18 In contrast, some clinical 
studies have demonstrated that intraoperative 
use of vasopressors has no negative effects on the 
microvascular ﬂap success rate.10,11
The results of recent studies measuring ﬂap 
blood ﬂow together with our results indicate that 
the vasoconstrictive effect of systemically admin-
istered norepinephrine in denervated free ﬂaps 
is markedly attenuated in the acute phase after 
microvascular reconstruction.1 A lack of denerva-
tion-induced hypersensitivity to vasoconstriction 
produced by α-adrenergic agents is also observed 
in pedicled ﬂaps.18 Autonomic nerve ﬁbers run-
ning along the anastomosed vessels are disrupted 
in free-ﬂap surgery, which changes the response 
of the vasodilated ﬂap vessels to vasopressors. This 
phenomenon is signiﬁcant and emphasizes the 
importance of studying metabolic and circulatory 
changes in the ﬂap itself during treatment with 
different vasopressors. The results of our study 
apply only to head and neck patients undergoing 
reconstruction with radial forearm ﬂaps. Further 
research should be performed to study the effect 
of vasopressors on perforator ﬂaps and in other 
anatomical areas such as lower limbs, to support 
its generalized use.
Scholz et al. evaluated the effect of dobuta-
mine on free-ﬂap blood ﬂow in arterial anasto-
mosis with an ultrasonic ﬂowmeter.3 Dobutamine 
improves free-ﬂap perfusion. Eley et al. reported 
promising results demonstrating that norepi-
nephrine causes less vasoconstriction in the free 
ﬂap than in the control skin during the periop-
erative period.1 Thus, the ﬂap skin blood ﬂow 
increases with an increase in the arterial blood 
pressure. Eley et al., however, also stated that 
acceptance of a small vasoconstrictor effect in 
return for a signiﬁcant improvement in ﬂap 
perfusion requires further validation to fully 
address concerns about the adverse effects of 
α-adrenergic agents on free tissue transfer. In 
their study, laser Doppler velocimetry was used 
to measure the skin blood ﬂow. Our ﬁndings 
support the safe use of norepinephrine and 
dopamine as vasopressors if necessary, at least 
during the ﬁrst 72 hours after microvascular 
anastomosis. Mean arterial pressure was success-
fully increased with both agents. The continuous 
tissue partial pressure of oxygen and lactate-to-
pyruvate ratio values in the ﬂaps did not differ 
signiﬁcantly between the norepinephrine, dopa-
mine, and control groups. These results provide 
further evidence that the use of norepinephrine 
and dopamine to maintain sufﬁcient mean arte-
rial pressure does not have adverse effects on 
free-ﬂap metabolism and circulation.
The patients in our study were treated with 
the objective of minimizing complications and 
side effects. Therefore, the infusion speed of the 
vasoactive drug was monitored tightly to maintain 
a preset mean arterial pressure range. In contrast, 
the drug dosage was ﬁxed beforehand in most of 
the previous studies, independent of the mean 
arterial pressure measurements.1,13,14,19 Even with 
close monitoring of the infusion speed, adverse 
effects were observed in the present study. We 
observed a heart rate increase in the dopamine 
group, which required a reduction in the dose of 
the vasoactive drug. In three patients treated with 
dopamine, the preset maximum dosage of infu-
sion was reached and yet the mean arterial pressure 
measurements remained low. This phenomenon 
was not observed in the norepinephrine group. 
For volume maintenance, all study patients were 
treated with crystalloids. Blood derivatives were 
Table 2. Mean Arterial Pressure and Heart Rate 
Measurements among the Study Group Patients after 
Head and Neck Ablative Surgery and Microvascular 
Reconstruction
Study Group Vasoactive Drug (mg) MAP HR
Norepinephrine Levophed, 9.8  
(range, 3–21) 83 ± 2 73 ± 9
Dopamine Abbodop, 558 mg 
(range, 144–1710) 79 ± 7 86 ± 20
Control Levophed, 2.9  
(range, 1–4*) 82 ± 8 89 ± 15
Abbodop, 8.8†
MAP, mean arterial pressure; HR, heart rate.
*Three patients.
†One patient.
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administered based on the patient’s hemoglobin 
values, comorbidities, estimated blood loss during 
surgery, and overall condition. The study patients’ 
blood loss was minimal and none required blood 
transfusion.
The Licox polarographic probe has gained 
great popularity in the neurosurgical ﬁeld and 
is a surgically implanted probe through which 
electrochemical changes allow for measurements 
of oxygen partial pressure of the tissue.20 Use of 
this method has become standard for head and 
neck free ﬂaps in our unit. Reconstructive sur-
geons quickly adopted the method for monitor-
ing microvascular ﬂaps, especially buried ﬂaps. 
Our team has published a positive experience 
with this valuable tool.21 Microdialysis allows for 
measurement of tissue glucose, pyruvate, and 
lactate concentrations, and analysis of their ratio 
predicts the presence of ischemia and aids the 
plastic surgeon in deciding whether the patient 
requires reoperation. In this method, a minicath-
eter is placed in the ﬂap subcutaneous tissue and 
the metabolites are sampled at various time inter-
vals.22,23 The Licox and microdialysate probes 
located in the ﬂap subcutaneous tissue provide 
uniform information about ﬂap perfusion. Inter-
estingly, the metabolite lactate-to-pyruvate ratio 
values found in our study were higher than the 
expected range (>22 to 25) but remained con-
stant throughout the observation period. The 
reason for this is unknown.
CONCLUSIONS
Although the use of vasopressors after micro-
vascular ﬂap reconstruction remains controver-
sial, there are few prospective studies in this area. 
Our research provides new information on free-
ﬂap metabolism and circulation when norepi-
nephrine or dopamine is used as a vasopressor 
to maintain sufﬁcient mean arterial pressure in 
patients undergoing head and neck reconstruc-
tion. Microvascular ﬂaps were monitored using 
two strongly sensitive methods that quantify tissue 
perfusion by partial tissue oxygenation and micro-
dialysate metabolites, making our ﬁndings repro-
ducible. The results indicate that norepinephrine 
and dopamine may be safely used during the 
immediate postoperative period after reconstruc-
tive head and neck microvascular surgery with 
the radial forearm ﬂap. Dopamine doses must 
be signiﬁcantly higher to maintain an optimal 
mean arterial pressure. Therefore, the risk of side 
effects is greater, and dopamine should be used 
with caution.
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